Meta Materials (MMATQ) 10-Q 9 Nov 22 2022 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2022	Nov. 09, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31
Entity Registrant Name	Meta Materials Inc.
Entity Central Index Key	0001431959
Entity File Number	001-36247
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Interactive Data Current	Yes
Entity Shell Company	false
Entity Small Business	true
Entity Emerging Growth Company	false
Document Quarterly Report	true
Document Transition Report	false
Entity Tax Identification Number	74-3237581
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	1 Research Drive
Entity Address, City or Town	Dartmouth
Entity Address, State or Province	NS
Entity Address, Postal Zip Code	B2Y 4M9
City Area Code	902
Local Phone Number	482-5729
Entity Common Stock, Shares Outstanding		361,930,468
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	MMAT
Security Exchange Name	NASDAQ

Condensed Consolidated Interim

Condensed Consolidated Interim Balance Sheets - USD ($)		Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents		$ 30,608,797	$ 46,645,704
Restricted Cash		436,123	788,768
Short-term investments		1,178,685	2,875,638
Grants receivable		26,062	175,780
Accounts receivable		1,977,676	1,665,700
Inventory		274,090	265,718
Prepaid expenses and other current assets		6,466,469	3,451,367
Assets held for sale		71,700,000	75,500,000
Due from related parties		8,552	10,657
Total current assets		112,676,454	131,379,332
Intangible assets, net		51,025,428	28,971,824
Property, plant and equipment, net		34,534,045	27,018,114
Operating lease right-of-use assets		5,366,070	6,278,547
Goodwill		279,052,357	240,376,634
Total assets		482,654,354	434,024,451
Current liabilities
Trade and other payables		12,818,253	13,335,470
Current portion of long-term debt		742,782	491,278
Current portion of deferred revenues		623,895	779,732
Current portion of deferred government assistance		783,055	846,612
Preferred stock liability		71,700,000	75,500,000
Current portion of operating lease liabilities		864,519	663,861
Asset retirement obligations		21,937	21,937
Total current liabilities		87,554,441	91,638,890
Deferred revenues		503,690	637,008
Deferred government assistance			3,038
Deferred tax liability		161,662	324,479
Long-term operating lease liabilities		3,177,910	3,706,774
Funding obligation		292,749	268,976
Long-term debt		2,137,948	2,737,171
Total liabilities		93,828,400	99,316,336
Stockholders' equity
Common stock - $0.001 par value; 1,000,000,000 shares authorized, 361,377,856 shares issued and outstanding at September 30, 2022, and $0.001 par value; unlimited shares authorized, 284,573,316 shares issued and outstanding at December 31, 2021		339,555	262,751
Additional paid-in capital		587,635,212	463,136,404
Accumulated other comprehensive loss		(6,862,090)	(296,936)
Accumulated deficit		(192,286,723)	(128,394,104)
Total stockholders' equity	[1]	388,825,954	334,708,115
Total liabilities and stockholders' equity		$ 482,654,354	$ 434,024,451
[1] Retroactively restated from the earliest period presented for the Torchlight RTO (“Reverse acquisition”) as described in Note 3

Condensed Consolidated Interi_2

Condensed Consolidated Interim Balance Sheets (Parenthetical) - $ / shares	12 Months Ended
	Dec. 31, 2021	Sep. 30, 2022
Statement of Financial Position [Abstract]
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized		1,000,000,000
Common Stock, Shares Authorized	Unlimited
Common Stock, Shares, Issued	284,573,316	361,377,856
Common Stock, Shares, Outstanding	284,573,316	361,377,856

Condensed Consolidated Interi_3

Condensed Consolidated Interim Statements of Operations And Comprehensive Loss - USD ($)		3 Months Ended		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenue:
Revenue		$ 2,456,012	$ 572,612	$ 8,754,434	$ 1,793,235
Cost of goods sold		696,730	145,103	2,353,393	146,209
Gross Profit		1,759,282	427,509	6,401,041	1,647,026
Operating Expenses:
Selling & Marketing		1,027,886	427,004	3,190,951	1,122,469
General & Administrative		16,674,309	9,776,850	45,743,892	16,217,012
Research & Development		6,233,685	1,816,547	16,693,833	5,229,456
Total operating expenses		23,935,880	12,020,401	65,628,676	22,568,937
Loss from operations		(22,176,598)	(11,592,892)	(59,227,635)	(20,921,911)
Interest expense, net		(134,205)	(215,116)	(440,694)	(1,093,833)
Loss on foreign exchange, net		(2,223,633)	(440,157)	(3,046,955)	(770,542)
Loss on financial instruments, net					(40,540,091)
Other (loss) income, net		21,908	739,260	(1,324,528)	1,673,124
Total other (expense) income, net		(2,335,930)	83,987	(4,812,177)	(40,731,342)
Loss before income taxes		(24,512,528)	(11,508,905)	(64,039,812)	(61,653,253)
Income tax recovery		37,208	83,657	147,193	186,183
Net loss	[1]	(24,475,320)	(11,425,248)	(63,892,619)	(61,467,070)
Other Comprehensive Income net of tax
Foreign currency translation loss		(4,413,860)	(125,976)	(6,565,154)	(17,328)
Fair value gain on changes of own credit risk					680,178
Total Other Comprehensive (Loss) Income	[1]	(4,413,860)	(125,976)	(6,565,154)	662,850
Comprehensive loss		$ (28,889,180)	$ (11,551,224)	$ (70,457,773)	$ (60,804,220)
Net loss per share, basic	[2]	$ (0.07)	$ (0.04)	$ (0.20)	$ (0.28)
Net loss per share, diluted	[2]	$ (0.07)	$ (0.04)	$ (0.20)	$ (0.28)
Weighted average number of shares outstanding - basic	[2]	362,260,641	280,080,786	316,661,487	216,135,190
Weighted average number of shares outstanding - diluted	[2]	362,260,641	280,080,786	316,661,487	216,135,190
Product sales [Member]
Revenue:
Revenue		$ 432,059	$ 297,431	$ 934,299	$ 321,431
Development revenue [Member]
Revenue:
Revenue		$ 2,023,953	$ 275,181	$ 7,820,135	$ 1,471,804
[1] Retroactively restated from the earliest period presented for the Torchlight RTO (“Reverse acquisition”) as described in Note 3 Retroactively restated for the nine months ended September 30, 2021 for the Torchlight RTO (“Reverse Acquisition”) as described in Note 3

Condensed Consolidated Interi_4

Condensed Consolidated Interim Statements of Changes in Stockholders' Equity - USD ($)		Total	Common Stock [Member]		Additional Paid-in Capital [Member]		Accumulated Other Comprehensive Income (Loss) [Member]	Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2020	[1]	$ (8,897,402)	$ 132,347		$ 29,021,974		$ (654,880)	$ (37,396,843)
Beginning balance, shares at Dec. 31, 2020	[1]		154,163,975
Net loss	[1]	(61,467,070)						(61,467,070)
Other comprehensive income (loss)	[1]	662,850					662,850
Conversion of promissory notes	[1]	23,656,365	$ 20,391		23,635,974
Conversion of promissory notes, Shares	[1]		20,391,239
Conversion of secured debentures	[1]	22,118,782	$ 14,156		22,104,626
Conversion of secured debentures, Shares	[1]		14,155,831
Conversion of unsecured debentures	[1]	5,769,475	$ 5,105		5,764,370
Conversion of unsecured debentures, Shares	[1]		5,105,338
Conversion of long-term debt	[1]	221,843	$ 125		221,718
Conversion of long-term debt, Shares	[1]		124,716
Conversion of payable to related party	[1]	225,986	$ 151		225,835
Conversion of payable to related party, Shares	[1]		150,522
Exercise of stock options	[1]	449,652	$ 1,640		448,012
Exercise of stock options, Shares	[1]		1,640,294
Exercise of warrants	[1]	93,994	$ 282		93,712
Exercise of warrants, Shares	[1]		287,114
Exercise of broker warrants	[1]	16,255	$ 61		16,194
Exercise of broker warrants, Shares	[1]		61,331
Issuance of stock in connection and Effect of reverse acquisition	[1]	369,631,002	$ 82,814		369,548,188
Stock Issued During Period for Acquisitions	[1]		82,813,994
Shares issued in lieu of operating lease liability	[1]	2,781,968	$ 1,833		2,780,135
Shares issued in lieu of operating lease liability, Shares	[1]		1,832,989
Stock-based compensation	[1]	5,269,407	$ 479		5,268,928
Stock-based compensation, Shares	[1]		478,562
Ending balance at Sep. 30, 2021	[1]	360,533,107	$ 259,384		459,129,666		7,970	(98,863,913)
Ending balance, shares at Sep. 30, 2021	[1]		281,205,905
Beginning balance at Jun. 30, 2021	[1]	367,914,349	$ 257,966		454,961,102		133,946	(87,438,665)
Beginning balance, shares at Jun. 30, 2021	[1]		279,782,854
Net loss	[1]	(11,425,248)						(11,425,248)
Other comprehensive income (loss)	[1]	(125,976)					(125,976)
Exercise of stock options	[1]	336,497	$ 1,226		335,271
Exercise of stock options, Shares	[1]		1,226,375
Exercise of warrants	[1]		$ 43		(43)
Exercise of warrants, Shares	[1]		48,308
Stock-based compensation	[1]	3,833,485	$ 149		3,833,336
Stock-based compensation, Shares	[1]		148,368
Ending balance at Sep. 30, 2021	[1]	360,533,107	$ 259,384		459,129,666		7,970	(98,863,913)
Ending balance, shares at Sep. 30, 2021	[1]		281,205,905
Beginning balance at Dec. 31, 2021	[1]	334,708,115	$ 262,751		463,136,404		(296,936)	(128,394,104)
Beginning balance, shares at Dec. 31, 2021	[1]		284,573,316
Net loss	[1]	(63,892,619)						(63,892,619)
Other comprehensive income (loss)	[1]	(6,565,154)					(6,565,154)
Issuance of common stock and warrants, Value	[1]	50,000,000	$ 37,037		49,962,963
Issuance of common stock and warrants shares	[1]		37,037,039
Stock issuance costs		(3,680,666)			(3,680,666)	[1]
Exercise of stock options	[1]	$ 337,793	$ 1,252		336,541
Exercise of stock options, Shares		1,252,546	1,252,546	[1]
Settlement of restricted stock units	[1]		$ 225		(225)
Settlement of restricted stock units, Shares	[1]		224,519
Exercise of warrants	[1]	$ 169,574	$ 1,624		167,950
Exercise of warrants, Shares	[1]		1,623,700
Issuance of stock in connection and Effect of reverse acquisition	[1]	67,122,512	$ 36,443		67,086,069
Stock Issued During Period for Acquisitions	[1]		36,443,684
Stock-based compensation	[1]	10,626,399	$ 223		10,626,176
Stock-based compensation, Shares	[1]		223,052
Ending balance at Sep. 30, 2022	[1]	388,825,954	$ 339,555		587,635,212		(6,862,090)	(192,286,723)
Ending balance, shares at Sep. 30, 2022	[1]		361,377,856
Beginning balance at Jun. 30, 2022	[1]	415,125,132	$ 338,987		585,045,778		(2,448,230)	(167,811,403)
Beginning balance, shares at Jun. 30, 2022	[1]		360,810,016
Net loss	[1]	(24,475,320)						(24,475,320)
Other comprehensive income (loss)	[1]	(4,413,860)					(4,413,860)
Exercise of stock options	[1]	32,472	$ 120		32,352
Exercise of stock options, Shares	[1]		120,269
Settlement of restricted stock units	[1]		$ 225		(225)
Settlement of restricted stock units, Shares	[1]		224,519
Stock-based compensation	[1]	2,557,530	$ 223		2,557,307
Stock-based compensation, Shares	[1]		223,052
Ending balance at Sep. 30, 2022	[1]	$ 388,825,954	$ 339,555		$ 587,635,212		$ (6,862,090)	$ (192,286,723)
Ending balance, shares at Sep. 30, 2022	[1]		361,377,856
[1] Retroactively restated from the earliest period presented for the Torchlight RTO (“Reverse acquisition”) as described in Note 3

Condensed Consolidated Interi_5

Condensed Consolidated Interim Statements of Cash Flows - USD ($)		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net loss	[1]	$ (63,892,619)	$ (61,467,070)
Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash finance income		(12,433)
Non-cash interest expense		419,684	904,749
Non- cash lease expense		1,212,415	256,785
Deferred income tax		(147,193)	(186,183)
Depreciation and amortization		5,377,470	1,798,607
Unrealized foreign currency exchange loss		2,843,223	279,805
Loss on financial instruments, net			40,540,091
Change in deferred revenue		(199,785)	(239,057)
Non-cash government assistance		(3,047)	(508,730)
Loss on debt settlement			19,253
Gain on sale of property, plant and equipment		(783)
Stock-based compensation		9,763,627	855,989
Non-cash consulting expense		862,771	3,926,628
Changes in operating assets and liabilities		(4,739,841)	(1,764,867)
Net cash used in operating activities		(48,516,511)	(15,584,000)
Cash flows from investing activities:
Purchases of intangible assets			(838,664)
Purchases of property, plant and equipment		(11,975,134)	(5,552,268)
Proceeds from sale of property, plant and equipment		39,140
Proceeds from short-term investments		1,620,281
Acquisition of business, net of cash acquired		(3,486,906)
Proceeds from reverse takeover			146,954,733
Net cash (used in) provided by investing activities		(13,802,619)	140,563,801
Cash flows from financing activities
Proceeds from the issuance of common stock and warrants		50,000,000
Costs paid on the issuance of common stock and warrants		(3,680,666)
Proceeds from long-term debt			1,127,151
Repayments of long-term debt		(467,767)	(938,496)
Proceeds from government grants			223,384
Proceeds from unsecured promissory notes			13,963,386
Proceeds from stock option exercises		337,793	374,652
Proceeds from warrants exercises		169,574	93,993
Proceeds from broker warrants exercises			16,255
Net cash provided by financing activities		46,358,934	14,860,325
Net (decrease) increase in cash, cash equivalents and restricted cash		(15,960,196)	139,840,126
Cash, cash equivalents and restricted cash at beginning of the period		47,434,472	1,395,683
Effects of exchange rate changes on cash, cash equivalents and restricted cash		(429,356)	(17,940)
Cash, cash equivalents and restricted cash at end of the period		31,044,920	141,217,869
Supplemental cash flow information
Accrued purchases of property, equipment, and patents		536,778	799,305
Right-of-use assets obtained in exchange for lease liabilities		$ 142,378	892,003
Right-of-use assets and prepaid expenses recognized in exchange for common stock			2,149,381
Settlement of liabilities in common stock			52,063,432
Interest paid on debt			$ 64,528
[1] Retroactively restated from the earliest period presented for the Torchlight RTO (“Reverse acquisition”) as described in Note 3

Corporate Information

Corporate Information	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Corporate Information	1. Corporate information Meta Materials Inc. (also referred to herein as the “Company”, “META”, “we”, “us”, “our”, or “Resulting Issuer”) is a smart materials and photonics company specializing in metamaterial research and products, nanofabrication, and computational electromagnetics. Our registered office is located at 85 Swanson Road, Boxborough, Massachusetts 01719 and our principal executive office is located at 1 Research Drive, Halifax, Nova Scotia, Canada. On December 14, 2020 , we (formerly known as “Torchlight Energy Resources, Inc.” or “Torchlight”) and our subsidiaries, Metamaterial Exchangeco Inc. (formerly named 2798832 Ontario Inc., “Canco”) and 2798831 Ontario Inc. (“Callco”), entered into an Arrangement Agreement (the “Arrangement Agreement”) with Metamaterial Inc., an Ontario corporation headquartered in Nova Scotia, Canada (“MMI”), to acquire all of the outstanding common stock of MMI by way of a statutory plan of arrangement (the “Arrangement”) under the Business Corporations Act (Ontario), on and subject to the terms and conditions of the Arrangement Agreement (the “Torchlight RTO”). On June 25, 2021, we implemented a reverse stock split. On June 28, 2021, following the satisfaction of the closing conditions set forth in the Arrangement Agreement, the Arrangement was completed, and we changed our name from “Torchlight Energy Resources, Inc.” to “Meta Materials Inc.” and changed our trading symbol from “TRCH” to “MMAT”. On June 28, 2021, and pursuant to the completion of the Arrangement Agreement, we began trading on the Nasdaq Capital Market under the symbol “MMAT” while MMI common stock was delisted from the Canadian Securities Exchange (“CSE”) and at the same time, Metamaterial Exchangeco Inc., a wholly-owned subsidiary of META, started trading under the symbol “MMAX” on the CSE. Certain previous shareholders of MMI elected to convert their common stock of MMI into exchangeable shares in Metamaterial Exchangeco Inc. These exchangeable shares, which can be converted into common stock of META at the option of the holder, are similar in substance to common shares of META and have been included in the determination of outstanding common shares of META. For accounting purposes, the legal subsidiary, MMI, has been treated as the accounting acquirer and the Company, the legal parent, has been treated as the accounting acquiree. The transaction has been accounted for as a reverse acquisition in accordance with ASC 805 Business Combinations . Accordingly, these condensed consolidated interim financial statements are a continuation of MMI consolidated financial statements prior to June 28, 2021 and exclude the balance sheets, statements of operations and comprehensive loss, statement of changes in stockholders’ equity and statements of cash flows of Torchlight prior to June 28, 2021. See note 3 for additional information.

Significant Accounting Policies

Significant Accounting Policies	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Significant Accounting Policies	2. Significant accounting policies Basis of presentation — These unaudited condensed consolidated interim financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States of America (“US GAAP”). Our fiscal year-end is December 31. The condensed consolidated interim financial statements include the accounts of Meta Materials Inc. and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated on consolidation. These unaudited condensed consolidated interim financial statements do not include all of the information and notes required by US GAAP for annual financial statements. Accordingly, these unaudited condensed consolidated interim financial statements should be read in conjunction with our audited consolidated financial statements and notes for the years ended December 31, 2021, 2020 and 2019, filed with the Securities and Exchange Commission (“SEC”) on Forms 10-K and 10-K/A, respectively. Recently Adopted Accounting Pronouncements: We currently have no material recently adopted accounting pronouncements. Recently Issued Accounting Pronouncements: We currently have no material recent accounting pronouncements yet to be adopted.

Acquisitions and Preferred Stoc

Acquisitions and Preferred Stock Liability	9 Months Ended
	Sep. 30, 2022
Acquisitions and Preferred Stock Liability [Abstract]
Acquisitions and Preferred Stock Liability	3. Acquisitions and preferred stock liability Torchlight RTO On June 28, 2021, we and our subsidiaries, Canco and Callco, completed an arrangement agreement where we acquired all of the outstanding common stock of MMI and the former shareholders of MMI acquired approximately 70 % of our Common Stock. Accordingly, the former shareholders of MMI, as a group, retained control of the Company, and while the Company was the legal acquirer of MMI, MMI was deemed to be the acquirer for accounting purposes. Pursuant to ASC 805 Business Combinations , the transaction was accounted for as a reverse acquisition. Consideration transferred was measured to be $ 358 million and the difference between the consideration transferred and fair value of net assets resulted in the recognition of goodwill of $ 213 million. We have finalized the purchase price allocation to the individual assets acquired and liabilities assumed using the acquisition method. There were no further changes to the purchase price allocation, as disclosed in the audited consolidated financial statements and notes for the years ended December 31, 2021 and 2020. Nanotech acquisition On October 5, 2021 , our wholly-owned subsidiary, 1315115 BC Ltd., purchased 100 % of the common stock of Nanotech Security Corp. ("Nanotech") at CA$ 1.25 per share. In addition, the transaction price included the settlement of certain Nanotech share awards outstanding immediately prior to the closing of the agreement. The consideration paid to the shareholders under the agreement resulted in a total purchase price of $ 72.1 million and the difference between the consideration paid and fair value of net assets resulted in the recognition of goodwill of $ 27.1 million. We believe that information gathered to date provides a reasonable basis for estimating the fair value of assets acquired and liabilities assumed, however we are waiting for additional information necessary to finalize these fair values including assessment of any tax assets and liabilities and tax position in different jurisdictions. Therefore, the provisional measurements of fair value are subject to change. We expect to complete the purchase price allocations as soon as practicable but no later than one year from the acquisition date. Plasma App Ltd acquisition On April 1, 2022 , we completed the purchase of 100 % of the issued and outstanding shares of Plasma App Ltd. ("PAL"). PAL is the developer of PLASMAfusion™, a proprietary manufacturing platform technology, which enables high speed coating of any solid material on any type of substrate. PAL’s team is located at the Rutherford Appleton Laboratories in Oxford, UK. At closing, we issued to PAL's shareholders an aggregate of 9,677,419 shares of our common stock, representing a number of shares of common stock equal to $ 18,000,000 divided by $ 1.9 (the volume weighted average price for the ten trading days ending on March 31, 2022) with an additional deferral of common stock equal to $ 2,000,000 divided by $ 1.9 to be issued subject to satisfaction of certain claims and warranties. The acquisition was accounted for as a business combination in accordance with ASC 805 “Business Combinations”. Under ASC 805, the consideration transferred is allocated based upon the fair value of the identifiable assets acquired and liabilities assumed on the acquisition date. We are in the process of completing the determination of the fair values of the assets acquired and liabilities assumed, including reviewing third-party valuations, the allocation of the intangibles and goodwill and tax effects related to the acquisition. Therefore, the provisional measurements of fair value are subject to change. We expect to complete the purchase price allocation as soon as practicable but no later than one year from the acquisition date. During the three months ended September 30, 2022, there were no changes to provisional amounts previously determined. Deferred Consideration We are obligated to issue to PAL shareholders an aggregate of 1,075,268 shares of our common stock on October 1, 2023, subject to reductions arising from general and specific claims and warranties that might arise of more than $ 20,000 and less than or equal to $ 2,000,000 . The number of shares were calculated as $ 2,000,000 divided by $ 1.9 (the volume weighted average price for the ten trading days ending on March 31, 2022). We have classified the deferred consideration in the statement of changes in stockholders’ equity since the number of shares to be issued is contractually specified in the agreement and is not contingent on a future event or condition being met. The preliminary allocation of consideration paid for the PAL acquisition is summarized as follows: Amount Fair value of common stock issued (1) $ 15,290,320 Fair value of deferred consideration (2) $ 1,698,925 $ 16,989,245 Net assets of Plasma App Ltd.: Cash and cash equivalents $ 13,822 Other assets 36,103 Intangibles 6,775,728 Goodwill 10,163,592 $ 16,989,245 (1) The fair value of the common stock issued or to be issued was determined by multiplying 9,677,419 shares, calculated as per the purchase agreement, by the closing share price on April 1, 2022 of $ 1.6 . We recognized $ 9,677 in common stock and $ 15,280,645 in additional paid in capital in the interim condensed consolidated statements of changes in stockholders' equity. (2) The estimated fair value of the deferred consideration on acquisition date was determined by multiplying 1,075,268 shares, calculated as per the purchase agreement, by the closing share price on April 1, 2022 of $ 1.6 . We recognized the full amount in additional paid in capital in the interim condensed consolidated statements of changes in stockholders' equity. Losses from the PAL acquisition since the acquisition date included in the c ondensed consolidated interim statements of operations and comprehensive los s for the three months and nine months ended September 30, 2022 were $ 0.3 million and $ 0.4 million, respectively. Transaction costs associated with the PAL Acquisition of $ 0.4 million were recognized in the c ondensed consolidated interim statements of operations and comprehensive los s for the three months ended September 30, 2022. Had the business combination occurred on January 1, 2021, the impact for the three months ended September 30, 2022 would have been an increase to revenue by $ Nil and a decrease in loss by $ Nil (2021 – increase to revenue by $ 118,122 and a decrease to loss by $ 44,953 ). Had the business combination occurred on January 1, 2021, the impact for the nine months ended September 30, 2022 would have been an increase to revenue by $ Nil and a decrease in loss by $ 259,641 (2021 – increase to revenue by $ 183,795 and a decrease to loss by $ 32,091 ). Optodot acquisition On June 22, 2022 , we completed an asset purchase agreement with Optodot Corporation ("Optodot"), a developer of advanced materials technologies, to acquire certain assets related to patents and intellectual property for the battery and other industries. Consideration transferred consisted of the following: 1. Cash payment of $ 3,500,000 . 2. Unrestricted common stock equal to $ 37,500,000 divided by the daily volume weighted average trading price per share of our common stock on the Nasdaq Capital Market for the consecutive period of twenty trading days ending on June 21, 2022. 3. Restricted common stock equal to $ 7,500,000 divided by the daily volume weighted average trading price per share of our Common Stock on the Nasdaq Capital Market for the consecutive period of twenty trading days ending on June 21, 2022. The restricted stock is subject to certain vesting milestones as set forth in the Purchase Agreement and outlined below. The acquisition was accounted for as a business combination in accordance with ASC 805, “Business Combinations”. Under ASC 805, the consideration transferred is allocated based upon the fair value of the identifiable assets acquired and liabilities assumed on the acquisition date. We are in the process of completing the determination of the fair values of the assets acquired and liabilities assumed, including reviewing third-party valuations, the allocation of the intangibles and goodwill and tax effects related to the acquisition. Therefore, the provisional measurements of fair value are subject to change. We expect to complete the purchase price allocation as soon as practicable but no later than one year from the acquisition date. During the three months ended September 30, 2022, there were no changes to provisional amounts previously determined. The preliminary allocation of consideration paid for the Optodot acquisition is summarized as follows: Amount Fair value of unrestricted common stock issued or to be issued (1) $ 41,791,115 Fair value of restricted common stock issued (2) 8,342,152 Cash consideration 3,500,000 Total consideration $ 53,633,267 Net assets of Optodot: Intangibles 21,453,306 Goodwill 32,179,961 $ 53,633,267 (1) The fair value of the unrestricted common stock issued or to be issued was determined by multiplying 22,348,190 shares, calculated as per the purchase agreement, by the closing share price on June 22, 2022 of $ 1.87 . We have issued 22,305,221 shares on the closing date of June 22, 2022 and 42,969 shares are yet to be issued. As of September 30, 2022, we recognized $ 22,305 in common stock and $ 41,768,810 in additional paid in capital in the interim condensed consolidated statements of changes in stockholders' equity. (2) The fair value of the restricted common stock issued was determined by multiplying 4,461,044 shares, calculated as per the purchase agreement, by the closing share price on June 22, 2022 of $ 1.87 . The restricted common stock is subject to vesting as follows: a) Two thirds or 2,974,029 shares shall be subject to the limitations on transfer until the earlier of (A) META's achievement of at least $ 5,000,000 in revenue, from any third-party source, to the extent resulting from the sale or license of Optodot IP during the year ended June 22, 2023 and (B) June 22, 2023; b) One third or 1,487,015 shares shall be subject to the limitations on transfer until the earlier of (A) META's achievement of at least $ 10,000,000 in revenue, from any third-party source, to the extent resulting from the sale or license of Optodot IP during the year ended June 22, 2024 and (B) June 22, 2024; Deferred Consideration Based on terms of the agreement outlined above and our consideration of ASC 805, we have classified the deferred consideration in the statement of changes in stockholders’ equity since the restricted shares have been already issued and the restriction will be removed at the end of the period specified. We are in the process of completing the determination of the fair values of the assets acquired and liabilities assumed, including reviewing third-party valuations and the allocation of the intangibles and goodwill. Accordingly, the preliminary values reflected in the table are subject to change. These changes will primarily relate to the fair value assigned to intangible assets acquired, goodwill determination and tax effects related to the acquisition. Losses from the Optodot acquisition since the acquisition date included in the condensed consolidated interim statements of operations and comprehensive loss for the period ended September 30, 2022 were $ 0.03 million. Transaction costs associated with the Optodot acquisition of $ 0.6 million were recognized in the c ondensed consolidated interim statements of operations and comprehensive los s for the nine months ended September 30, 2022. Had the business combination occurred on January 1, 2021, the impact for the three months ended September 30, 2022 would have been an increase to revenue by $ Nil and an increase in loss by $ Nil (2021 – an increase to revenue by $ Nil and an increase to loss by $ 469,090 ). Had the business combination occurred on January 1, 2021, the impact for the nine months ended September 30, 2022 would have been an increase to revenue by $ 41,871 and an increase in loss by $ 772,395 (2021 – an increase to revenue by $ 121,530 and an increase to loss by $ 1,393,035 ).

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2022
Related Party Transactions [Abstract]
Related party transactions	4. Related party transactions As of September 30, 2022, and December 31, 2021, receivables due from a related party (Lamda Guard Technologies Ltd, or “LGTL”) were $ 8,552 and $ 10,657 , respectively.

Assets Held for Sale

Assets Held for Sale	9 Months Ended
	Sep. 30, 2022
Assets Held for Sales Disclosure [Abstract]
Assets Held for Sale	5. Assets held for sale As of September 30, 2022 and December 31, 2021, assets held for sale represent the acquired oil and natural gas properties from the Torchlight RTO. Orogrande Project, West Texas Our outstanding drilling obligation includes five wells in 2022 and 2023. All drilling obligations through December 31, 2021 have been met. The drilling obligations are minimum yearly requirements and may be exceeded if acceleration is desired. During the three and nine months ended September 30, 2022, we have incurred an additional $ 0.1 million and $ 1.6 million , respectively, in costs to meet compliance requirements with the relevant leases. We have obtained an updated valuation study performed by a third-party valuation firm to estimate the fair value of the Orogrande project assets and the related preferred stock dividends liability. The estimates involved are consistent with those outlined as part of the acquisition. The valuation concluded an implied enterprise value to be between $ 53.0 million and $ 108.7 million. We recorded the fair value of the Orogrande Project property at $ 71.7 million as the median value. The Orogrande Project ownership as of September 30, 2022 is detailed as follows: Revenue Interest Working Interest University Lands - Mineral Owner 20.00 % n/a ORRI - Magdalena Royalties, LLC, an entity controlled by Gregory McCabe, Chairman 4.50 % n/a ORRI - Unrelated Party 0.50 % n/a Hudspeth Oil Corporation, a subsidiary of Meta Materials Inc. 49.88 % 66.50 % Wolfbone Investments LLC, an entity controlled by Gregory McCabe, Chairman 18.75 % 25.00 % Conversion by Note Holders in March, 2020 4.50 % 6.00 % Unrelated Party 1.88 % 2.50 % 100.00 % 100.00 % Hazel Project in the Midland Basin in West Texas As previously disclosed in the condensed consolidated interim financial statements for the three months ended March 31, 2022, we concluded that the fair value of the Hazel Project property is $ Nil based on an engineering reserve report prepared by PeTech Enterprises, Inc. ("PeTech"), a third-party Reserve Engineer. The calculations were prepared using standard geological and engineering methods generally accepted by the petroleum industry and in accordance with SEC financial accounting and reporting standards.

Inventory

Inventory	9 Months Ended
	Sep. 30, 2022
Inventory Disclosure [Abstract]
Inventory	6. Inventory Inventory consists of photosensitive materials, lenses, laser protection film and finished eyewear, and is comprised of the following: As of September 30, December 31, Raw materials $ 154,267 $ 196,868 Supplies 11,584 8,886 Work in process 61,618 30,636 Finished goods 46,621 29,328 Total inventory $ 274,090 $ 265,718

Property, Plant and Equipment,

Property, Plant and Equipment, Net	9 Months Ended
	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment, Net	7. Property, plant and equipment, net Property, plant and equipment consist of the following: Useful life As of (years) September 30, December 31, Land N/A $ 434,084 $ 469,317 Building 25 5,019,494 5,509,403 Computer equipment 3 - 5 422,405 262,320 Computer software 1 304,306 277,717 Manufacturing equipment 2 - 5 22,243,051 17,762,405 Office furniture 5 - 7 577,426 525,961 Enterprise Resource Planning software 5 195,297 211,149 Leasehold Improvements 5 2,380,428 236,251 Assets under construction N/A 12,127,399 8,872,695 43,703,890 34,127,218 Accumulated depreciation and impairment ( 9,169,845 ) ( 7,109,104 ) $ 34,534,045 $ 27,018,114 Depreciation expense was $ 1.0 million and $ 0.4 million for the three months ended September 30, 2022, and 2021, respectively, and $ 2.6 million and $ 1.1 million for t he nine months ended September 30, 2022 and 2021, respectively. Property, plant and equipment is pledged as security under a General Security Agreement (a “GSA”) signed in favor of the Royal Bank of Canada (“RBC”) on July 14, 2014, which is related to our corporate bank account and credit card and includes all property, plant and equipment and intangible assets.

Intangible Assets and Goodwill

Intangible Assets and Goodwill	9 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Goodwill	8. Intangible assets and goodwill Intangible assets consist of the following: Useful life As of (years) September 30, December 31, Patents 5 - 10 $ 34,019,095 $ 7,839,182 Trademarks N/A 122,423 132,636 Developed technology 20 13,810,462 14,931,377 Customer contract 5 9,484,205 10,253,983 57,436,185 33,157,178 Accumulated amortization ( 6,410,757 ) ( 4,185,354 ) $ 51,025,428 $ 28,971,824 Amortization expense was $ 0.9 million and $ 0.2 million for the three months ended September 30, 2022, and 2021, respectively, and $ 2.8 million and $ 0.7 million for t he nine months ended September 30, 2022 and 2021 respectively. Patent additions include a provisional amount of $ 6.8 million in acquired patents as part of the PAL acquisition, subject to change, and $ 21.5 million in acquired patents as part of the Optodot acquisition, subject to change. See Note 3. Goodwill Goodwill at December 31, 2021 $ 240,376,634 Business combination 10,163,592 Effect of foreign exchange on goodwill 28,512,131 Goodwill at September 30, 2022 $ 279,052,357 Goodwill is tested for impairment annually as of December 31 or more frequently when events or changes in circumstances indicate that impairment may have occurred. As of September 30, 2022, goodwill include a provisional amount of $ 8.5 million as part of the PAL acquisition, subject to change, and $ 32.2 million as part of the Optodot acquisition, subject to change.

Long-Term Debt

Long-Term Debt	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Long-term debt	9. Long-term debt As of September 30, December 31, ACOA Business Development Program (“BDP”) 2012 interest-free loan 1 with a maximum contribution of CA$ 500,000 , repayable in monthly repayments commencing October 1, 2015 of CA$ 5,952 until June 1, 2023 . Loan repayments were temporarily paused effective April 1, 2020 until January 1, 2021 as a result of the COVID-19 outbreak. As at September 30, 2022, the amount drawn down on the loan, net of repayments, is CA$ 53,571 (December 31, 2021 - CA$ 107,143 ). $ 38,058 $ 80,390 ACOA Atlantic Innovation Fund (“AIF”) 2015 interest-free loan 1,2 with a maximum contribution of CA$ 3,000,000 . Annual repayments, commencing June 1, 2021 , are calculated as a percentage of gross revenue for the preceding fiscal year, at Nil when gross revenues are less than CA$ 1,000,000 , 5 % when gross revenues are less than CA$ 10,000,000 and greater than CA$ 1,000,000 , and CA$ 500,000 plus 1 % of gross revenues when gross revenues are greater than CA$ 10,000,000 . As at September 30, 2022, the amount drawn down on the loan is CA$ 2,661,293 (December 31, 2021 - CA$ 2,924,615 ). 1,513,930 1,666,764 ACOA BDP 2018 interest-free loan 1,3 with a maximum contribution of CA$ 3,000,000 , repayable in monthly repayments commencing June 1, 2021 of CA$ 31,250 until May 1, 2029 . As at September 30, 2022, the amount drawn down on the loan, net of repayments, is CA$ 2,500,000 (December 31, 2021 - CA$ 2,781,250 ). 1,148,679 1,319,130 ACOA BDP 2019 interest-free loan 1 with a maximum contribution of CA$ 100,000 , repayable in monthly repayments commencing June 1, 2021 of CA$ 1,400 until May 1, 2027 . As at September 30, 2022, the amount drawn down on the loan, net of repayments, is CA$ 77,778 (December 31, 2021 - CA$ 90,278 ). 35,560 42,011 ACOA Regional Relief and Recovery Fund (“RRRF”) 2020 interest-free loan with a maximum contribution of CA$ 390,000 , repayable on monthly repayments commencing April 1, 2023 of CA$ 11,000 until April 1, 2026 . As at September 30, 2022, the amount drawn down on the loan is CA$ 390,000 (December 31, 2021 - CA$ 390,000 ). 144,503 120,154 2,880,730 3,228,449 Less: current portion 742,782 491,278 $ 2,137,948 $ 2,737,171 1 We were required to maintain a minimum balance of positive equity throughout the term of the loan. However, on November 14, 2019, ACOA waived this requirement for the period ending June 30, 2019 and for each period thereafter until the loan is fully repaid. 2 The carrying amount of the ACOA AIF loan is reviewed each reporting period and adjusted as required to reflect management’s best estimate of future cash flows, discounted at the original effective interest rate. 3 A portion of the ACOA BDP 2018 loan was used to finance the acquisition and construction of manufacturing equipment resulting in $ 425,872 was recorded as deferred government assistance, which is being amortized over the useful life of the associated equipment. We recorded amortization expense for the three and nine months ended September 30, 2022 of $ Nil and $ 3,047 , respectively compared to recorded amortization expense of $ 35,404 and $ 109,497 , for the three and nine months ended September 30, 2021 respectively) as government assistance in the condensed consolidated interim statements of operations and comprehensive loss. As of September 30, 2022, the portion recorded as deferred government assistance is amortized in full.

Capital Stock

Capital Stock	9 Months Ended
	Sep. 30, 2022
Stockholders' Equity Note [Abstract]
Capital Stock	10. Capital stock Common stock Authorized: 1,000,000,000 common shares, $ 0.001 par value. All references to numbers of common shares and amounts in the condensed consolidated interim statements of changes in stockholder’s equity and in the notes to the condensed consolidated interim financial statements have been retroactively restated to reflect as if the Torchlight RTO had taken place as of the beginning of the earliest period presented. • The number of common shares issued pre-Torchlight RTO have been multiplied by the 1.845 Torchlight conversion ratio. • The amounts of common shares issued pre-Torchlight RTO were calculated by multiplying the number of shares by 0.001 and the 1.845 Torchlight conversion ratio and the difference were recognized in additional paid in capital. During the nine months ended September 30, 2022, 1,988,617 warrants were exercised to purchase 1,623,700 common shares where most warrant holders elected cashless exercise and consequently, the difference of 364,929 shares was withheld to cover the exercise cost. During th e nine months ended September 30, 2022, 1,252,546 stock options were exercised to purchase an equal number of com mon shares. In addition, 224,519 restricted stock units have vested and settled into an equal number of common shares. During th e nine months ended September 30, 2022, we issued 9,677,419 common stock as consideration in relation to the PAL acquisition and 26,766,265 as consideration in relation to the Optodot acquisition (note 3). During th e nine months ended September 30, 2022, we issued 223,052 common shares at $ 1.87 as a compensation to a service provider in relation to the Optodot acquisition. Registered direct offering On June 24, 2022, we entered into a securities purchase agreement, as amended and restated on June 27, 2022, with certain institutional investors (the “SPA”) for the purchase and sale in a registered direct offering of 37,037,039 shares of our common stock at a purchase price of $ 1.35 per share and warrants to purchase 37,037,039 shares at an exercise price of $ 1.75 per share. This resulted in gross proceeds from the offering of $ 50 million and net proceeds of $ 46.3 million. The gross proceeds were allocated between common stock and accompanying warrants based on their relative fair values. The fair value of common stock was calculated based on the closing share price on June 27, 2022 of $ 1.15 . The fair value of the warrants was estimated using the Black-Scholes option pricing model. Accordingly, we have allocated $ 27.9 million as the fair value of common stock and $ 18.5 million as the fair value of warrants. The warrants are exercisable six months after the date of issuance, expire five and a half years from the date of issuance and have an exercise price of $ 1.75 per share of common stock. We have evaluated the warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants’ specific terms and applicable authoritative guidance in ASC 480, “Distinguishing Liabilities from Equity” and ASC 815, “Derivatives and Hedging”. We have concluded that the warrants are considered indexed to our common shares and as such they have been classified as equity. Warrants The following table summarizes the changes in our warrants: Nine months ended September 30, 2022 Number of warrants (#) Amount Outstanding, December 31, 2021 5,264,959 $ 6,957,974 Issued 37,337,039 18,714,297 Exercised ( 1,988,617 ) ( 251,860 ) Expired ( 692,462 ) ( 101,211 ) Outstanding, September 30, 2022 39,920,919 $ 25,319,200 On May 10, 2022, our Board of Directors approved a grant to a non-employee of 300,000 fully vested warrants, which have a 5-year term. The warrants have an exercise price of $ 1.18 per share, based on the closing price of our common stock on May 10, 2022. On June 27, 2022, we issued 37,037,039 warrants exercisable six months after the date of issuance, expire five and a half years from the date of issuance and have an exercise price of $ 1.75 per share of common stock as part of the registered direct offering. The fair value of warrants issued were estimated using the Black-Scholes option pricing model and have the following inputs and assumptions: Nine months ended September 30, 2022 Weighted average grant date fair value 0.53 Weighted average expected volatility 89 % Weighted average risk-free interest rate 3.18 % Weighted average expected life of the warrants 5.00

Share-Based Payments

Share-Based Payments	9 Months Ended
	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Share-based payments	11. Stock-based payments On December 3, 2021, our shareholders approved the 2021 Equity Incentive Plan to utilize the 3,500,000 shares reserved and unissued under the Torchlight 2015 Stock Option and Grant Plan and the 6,445,745 shares reserved and unissued under the MMI 2018 Stock Option and Grant plan to set the number of shares reserved for issuance under the 2021 Equity Incentive Plan at 34,945,745 shares. The 2021 Equity Incentive Plan allows the grants of non-statutory stock options, restricted stock, restricted stock units ("RSUs"), stock appreciation rights, performance units and performance shares to employees, directors, and consultants. DSU Plan On March 28, 2013, we implemented a Deferred Stock Unit (DSU) Plan for our directors, employees and officers. Directors, employees and officers are granted DSUs with immediate vesting as a form of compensation. Each unit is convertible at the option of the holder into one common share. Eligible individuals are entitled to receive all DSUs (including dividends and other adjustments) no later than December 1st of the first calendar year commencing after the time of termination of their services. As of September 30, 2022, there were 3,647,026 outstanding DSUs. There were no new DSUs issued, no DSUs exercised and no DSUs expired during the nine months ended September 30, 2022. RSU Plan Each unit is convertible at the option of the holder into one common share of our shares upon meeting the vesting conditions. Total stock-based compensation expense related to RSUs included in the condensed consolidated interim statements of operations was as follows: Three months ended Nine months ended September 30, September 30, 2022 2021 2022 2021 Cost of sales $ 167,779 - $ 376,250 - Selling & marketing 101,165 - 231,365 - General & administrative 519,769 - 1,036,931 - Research & development 447,707 - 1,640,939 - $ 1,236,420 - $ 3,285,485 - The following table summarizes the change in outstanding RSUs: Number of Weighted Outstanding, December 31, 2021 300,000 $ 6.43 Granted 6,676,598 3.15 Awards forfeited ( 217,445 ) 1.62 Awards vested and settled ( 224,519 ) 1.09 Outstanding, September 30, 2022 6,534,634 $ 3.31 Vested, September 30, 2022 606,919 $ 1.58 Employee Stock Option Plan Each stock option is convertible at the option of the holder into one common share upon payment of exercise price. Total stock-based compensation expense related to stock options included in the condensed consolidated interim statements of operations and comprehensive loss was as follows: Three months ended Nine months ended September 30, September 30, 2022 2021 2022 2021 Selling & marketing $ 53,543 $ 5,976 $ 118,598 $ 26,935 General & administrative 506,392 93,453 4,775,793 434,135 Research & development 344,067 101,347 1,583,794 383,489 $ 904,002 $ 200,776 $ 6,478,185 $ 844,559 The following table summarizes the change in our outstanding stock options: Number of Weighted Weighted Aggregate intrinsic Outstanding, December 31, 2021 21,404,641 $ 0.36 $ 7.34 $ 56,924,556 Granted 12,150,571 1.68 Forfeited ( 200,896 ) 0.74 Exercised ( 1,252,546 ) 0.27 Outstanding, September 30, 2022 32,101,770 $ 0.86 $ 9.00 $ 7,190,452 X Exercisable, September 30, 2022 22,233,380 $ 0.80 $ 8.18 $ 5,958,166 Below is a summary of the outstanding options as of September 30, 2022 and December 31, 2021: September 30, December 31, 2022 2021 Exercise price Number outstanding Number exercisable Number outstanding Number exercisable $ 0.12 518,112 518,113 518,112 518,112 0.15 369,000 369,000 369,000 369,000 0.27 17,714,087 14,471,227 19,067,529 10,893,918 0.94 957,274 45,000 — — 1.00 375,000 375,000 375,000 325,000 1.17 1,730,138 386,087 — — 1.21 1,119,120 552,752 — — 1.51 741,987 741,987 — — 1.58 5,107,941 1,305,103 — — 1.97 1,894,111 1,894,111 — — 2.00 1,075,000 1,075,000 1,075,000 1,125,000 3.47 200,000 200,000 — — 7.96 300,000 300,000 — — 32,101,770 22,233,380 21,404,641 13,231,030 The fair value of options granted was estimated at the grant date using the following weighted-average assumptions: Nine months ended September 30, Grant date fair value 0.90 Weighted average expected volatility 83 % Weighted average risk-free interest rate 2.23 % Weighted average expected life of the options 4.71 years Where possible, we use the simplified method to estimate the expected term of employee stock options. We do not have adequate historical exercise data to provide a reasonable basis for estimating the expected term for the current share options granted. The simplified method assumes that employees will exercise share options evenly between the period when the share options are vested and ending on the date when the options would expire. The expected volatility reflects the assumption that the historical volatility over a period similar to the life of the options is indicative of future trends, which may not necessarily be the actual outcome.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	12. Income taxes We estimate our annual effective income tax rate in recording our quarterly provision for income taxes in the various jurisdictions in which we operate. Statutory tax rate changes and other significant or unusual items are recognized as discrete items in the quarter in which they occur. Our effective tax rate for the three and nine months ended September 30, 2022 differs from the statutory rates due to valuation allowance as well as different domestic and foreign statutory tax rates. Deferred tax recovery for the three and nine months ended September 30, 2022 and 2021 was as follows: Three months ended Nine months ended September 30, September 30, 2022 2021 2022 2021 Deferred tax recovery $ 37,208 $ 83,657 $ 147,193 $ 186,183 We have not yet been able to establish profitability or other sufficient significant positive evidence, to conclude that our deferred tax assets are more likely than not to be realized. Therefore, we continue to maintain a valuation allowance against our deferred tax assets.

Net Loss Per Share

Net Loss Per Share	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Net loss per share	13. Net loss per share The following table sets forth the calculation of basic and diluted net loss per share during the periods presented: Three months ended Nine months ended September 30, September 30, 2022 2021 2022 2021 Numerator: Net loss $ ( 24,475,320 ) $ ( 11,425,248 ) $ ( 63,892,619 ) $ ( 61,467,070 ) Denominator: Weighted-average shares, basic 362,260,641 280,080,786 316,661,487 216,135,190 Weighted-average shares, diluted 362,260,641 280,080,786 316,661,487 216,135,190 Net loss per share Basic $ ( 0.07 ) $ ( 0.04 ) $ ( 0.20 ) $ ( 0.28 ) Diluted $ ( 0.07 ) $ ( 0.04 ) $ ( 0.20 ) $ ( 0.28 ) The following potentially dilutive shares were not included in the calculation of diluted shares above as the effect would have been anti-dilutive: Three months ended Nine months ended September 30, September 30, 2022 2021 1 2022 2021 1 Options 32,101,770 24,572,014 32,101,770 24,572,014 Warrants 39,920,919 5,372,044 39,920,919 5,372,044 DSUs 3,647,026 3,455,224 3,647,026 3,455,224 RSUs 6,534,634 - 6,534,634 - 82,204,349 33,399,282 82,204,349 33,399,282 1 All references to numbers in comparative figures have been retroactively restated to reflect the number of stock of the legal parent (accounting acquiree) issuable following the reverse acquisition. The numbers of options, warrants, and DSUs issued pre-Torchlight RTO have been multiplied by 1.845 Torchlight conversion ratio.

Additional Cash Flow Informatio

Additional Cash Flow Information	9 Months Ended
	Sep. 30, 2022
Supplemental Cash Flow Elements [Abstract]
Additional Cash Flow Information	14. Additional cash flow information The net changes in non-cash working capital balances related to operations consist of the following: Nine months ended September 30, 2022 2021 Grants receivable $ 145,704 $ 38,544 Inventory ( 31,543 ) 103,831 Other receivables ( 385,541 ) ( 73,436 ) Prepaid expenses ( 1,318,903 ) ( 1,342,530 ) Other current assets ( 1,961,928 ) ( 598,307 ) Trade payables ( 445,489 ) ( 258,128 ) Due from related party ( 2,105 ) ( 24,889 ) Operating lease Right-of-use Asset ( 231 ) 408,430 Operating lease liabilities ( 739,805 ) ( 18,382 ) $ ( 4,739,841 ) $ ( 1,764,867 )

Fair value measurements

Fair value measurements	9 Months Ended
	Sep. 30, 2022
Financial Instruments Disclosure [Abstract]
Fair value measurements	15. Fair value measurements We use a fair value hierarchy, based on the relative objectivity of inputs used to measure fair value, with Level 1 representing inputs with the highest level of objectivity and Level 3 representing the lowest level of objectivity. The fair values of cash and cash equivalents, restricted cash, short-term investments, grants and accounts receivables, due from related parties and trade and other payables approximate their carrying values due to the short-term nature of these instruments. The current portion of long-term debt has been included in the below table. The fair value of assets held for sale is classified as level 3 as the fair value of the O&G assets was estimated by obtaining a valuation study performed by a third-party valuator and an engineering reserve report. The fair value of the preferred stock liability is classified as level 3 since the fair value measurement of the oil and natural gas properties forms the basis for the fair value measurement of the preferred stock liability as of September 30, 2022. The fair values of the funding obligation, operating lease liabilities, and long-term debt would be classified at Level 3 in the fair value hierarchy, as each instrument is estimated based on unobservable inputs including discounted cash flows using the market rate, which is subject to similar risks and maturities with comparable financial instruments as of the reporting date. Carrying values and fair values of financial instruments that are not carried at fair value are as follows: September 30, December 31, Financial liability Carrying value Fair value Carrying value Fair value Funding obligation $ 292,749 $ 189,020 $ 268,976 $ 170,338 Operating lease liabilities 4,042,429 5,268,962 4,370,635 6,149,369 Long-term debt 2,880,730 1,884,660 3,228,449 2,303,648

Revenue

Revenue	9 Months Ended
	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Revenue	16. Revenue We have one operating segment based on how management internally evaluates separate financial information, business activities and management responsibility. Revenue is disaggregated as follows: Three months ended Nine months ended September 30, September 30, 2022 2021 2022 2021 Product sales $ 432,059 $ 297,431 $ 934,299 $ 321,431 Contract revenue 1 2,003,953 275,181 7,700,135 1,229,648 Other development revenue 20,000 — 120,000 242,156 Development revenue 2,023,953 275,181 7,820,135 1,471,804 $ 2,456,012 $ 572,612 $ 8,754,434 $ 1,793,235 1 A portion of contract revenue represents previously recorded deferred revenue that was recognized as revenue after satisfaction of performance obligations either through passage of time or after completion of specific performance milestones. Customer concentration A significant amount of our revenue is derived from contracts with major customers. For the three and nine months ended September 30, 2022, revenue from one customer accounted fo r $ 2.0 million or 82 % and $ 7.5 million or 86 % respectively of total revenue. We currently derive a significant portion of our revenue from contract services with a G10 central bank. In 2021, we acquired a development contract for up to $ 41.5 million over a period of up to five years . These contract services incorporate both nano-optic and optical thin film technologies and are focused on developing authentication features for future banknotes. For the three and nine months ended September 30, 2021, we had one customer that accounted for $ 0.3 million or 51 % and $ 0.7 million or 40 % respectively of total revenue.

Deferred Revenue

Deferred Revenue	9 Months Ended
	Sep. 30, 2022
Deferred Revenue Disclosure [Abstract]
Deferred Revenue	17. Deferred Revenue Deferred revenue consists of the following: September 30, December 31, Satair A/S-exclusive rights $ 592,626 $ 717,615 Satair A/S-advance against PO 454,075 490,929 LM Aero-MetaSOLAR commercialization — 92,698 US Deferred Revenue 75,000 75,000 Innovate UK-R&D tax credit — 18,588 Other deferred revenue 5,884 21,910 1,127,585 1,416,740 Less current portion 623,895 779,732 $ 503,690 $ 637,008

Loss on financial instruments,

Loss on financial instruments, net	9 Months Ended
	Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Loss on financial instruments, net	18. Loss on financial instruments, net Three months ended Nine months ended September 30, September 30, 2022 2021 2022 2021 Loss on unsecured convertible promissory notes – Bridge loan $ — $ — $ — $ ( 19,163,417 ) Gain on unsecured convertible promissory notes – Torchlight notes — — — ( 343,197 ) Loss on secured convertible debentures — — — ( 16,957,029 ) Loss on unsecured convertible debentures — — — ( 4,076,448 ) $ — $ - $ — $ ( 40,540,091 )

Leases

Leases	9 Months Ended
	Sep. 30, 2022
Leases [Abstract]
Leases	19. Leases We entered into the following lease during the nine months ended September 30, 2022: Burnaby lease expansion On February 25, 2022, we entered into an agreement to amend our Burnaby lease ("expansion"), to expand the premises by an additional 1,994 square feet, commencing on June 1, 2022 , for a period of two years and eleven months . The agreement provides the tenant with early access to the premises at least three months prior to the commencement date to conduct leasehold improvements. We obtained access to the premises on March 25, 2022 and consequently recognized a right-of-use asset and liability for the expansion as of June 30, 2022, of $ 146,822 . Total operating lease expense included in the condensed consolidated interim statements of operations and comprehensive loss is as follows: Three months ended Nine months ended September 30, September 30, 2022 2021 2022 2021 Operating lease expense $ 440,649 $ 87,193 $ 1,326,370 $ 187,314 Short term lease expense 199,637 86,746 358,877 140,074 Variable and other lease expense 59,678 25,244 174,021 53,128 Total $ 699,964 $ 199,183 $ 1,859,268 $ 380,516 We have elected the practical expedient in ASC 842 " Leases " to not capitalize any leases with initial terms of less than twelve months on our balance sheet and include them as short-term lease expense in the condensed consolidated interim statements of operations and comprehensive loss. Future minimum payments under non-cancelable operating lease obligations were as follows as of September 30, 2022: Remainder of 2022 $ 292,037 2023 1,166,619 2024 1,167,031 2025 1,057,062 2026 897,640 Thereafter 2,671,110 Total minimum lease payments 7,251,499 Less: interest ( 3,209,070 ) Present value of net minimum lease payments 4,042,429 Less: current portion of lease liabilities ( 864,519 ) Total long-term lease liabilities $ 3,177,910

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	20. Commitments and contingencies Legal Matters Datalog LWT On April 30, 2020, our wholly owned subsidiary, Hudspeth Oil Corporation, filed suit against Datalog LWT, Inc. d/b/a Cordax Evaluation Technologies. The suit, Hudspeth Oil Corporation and Wolfbone Investments, LLC v. Datalog LWT, Inc. d/b/a Cordax Evaluation Technologies, was filed in the 189th Judicial District Court of Harris County, Texas. The suit seeks the recovery of approximately $ 1.4 million in costs incurred as a result of a tool failure during drilling activities on the University Founders A25 #2 well that is located in the Orogrande Field. Working interest owner Wolfbone Investments, LLC, a company owned by our former Chairman Gregory McCabe, is a co-plaintiff in that action. After the suit was filed, Cordax filed a mineral lien in the amount of $ 104,500 against the Orogrande Field and has sued the operator and counterclaimed against Hudspeth for breach of contract, seeking the same amount as the lien. We have added the manufacturer of one of the tool components that we contend was a cause of the tool failure. It was later discovered that Datalog LWT, Inc. d/b/a Cordax Evaluation Technologies forfeited its charter to conduct business in the State of Texas by failing to timely pay its franchise taxes, and we added members of the board of directors to the case pursuant to the Texas Tax Code. It was recently disclosed that Datalog LWT, Inc. d/b/a Cordax Evaluation Technologies is the subsidiary of a Canadian parent company, Cordax Evaluation Technologies, Inc., who has also been added to the case. Cordax’s current Chairman of the Board filed a special appearance after being served with citation, alleging that he was a Canadian citizen with no meaningful ties to Texas. After discovery was conducted on this issue, a nonsuit without prejudice for this Defendant was filed, dismissing him from the case. The remaining parties attended mediation on June 15, 2022, that was unsuccessful in resolving the case. The parties are now engaged in discovery and plan to take depositions of fact and expert witnesses. We are currently identifying and vetting potential expert witnesses. Management is open to an agreed resolution if such an agreement can be reached but is prepared to proceed to trial on the claims, which is currently set for April 17, 2023. On March 18, 2021, Datalog LWT, Inc. d/b/a Cordax Evaluation Technologies filed a lawsuit in Hudspeth County, Texas seeking to foreclose its mineral lien against the Orogrande Field in the amount of $ 104,500.01 and recover related attorney’s fees. The foreclosure action, Datalog LWT Inc. d/b/a Cordax Evaluation Technologies v. Torchlight Energy Resources, Inc., was filed in the 205th Judicial District Court of Hudspeth County, Texas. We are contesting the lien in good faith and filed a Plea in Abatement on May 10, 2021, seeking a stay in the Hudspeth County lien foreclosure case pending final disposition of the related case currently pending in Harris County, Texas. SEC Subpoena In September 2021, we received a subpoena from the Securities and Exchange Commission, Division of Enforcement, in a matter captioned In the Matter of Torchlight Energy Resources, Inc. The subpoena requests that we produce certain documents and information related to, among other things, the merger involving Torchlight Energy Resources, Inc. and Metamaterial Inc. We are cooperating and intend to continue to cooperate with the SEC’s investigation. We can offer no assurances as to the outcome of this investigation or its potential effect, if any, on us or our results of operation. Securities Class Action Lead plaintiffs filed a consolidated complaint on August 29, 2022. We moved to dismiss that complaint on October 13, 2022. Shareholder Derivative Action Westpark Capital Group 450,000 commission as a placement agent with respect to our June 2022 direct offering. On August 31, 2022, we filed an answer to the complaint. We dispute that WestPark Capital Group placed the investor in the direct offering and is owed a commission. Contractual Commitments and Purchase Obligations a) On January 29, 2021, we arranged an irrevocable standby letter of credit with Toronto Dominion Bank (“TD”) in favor of Covestro Deutschland AG (“Covestro”) for EUR 600,000 in relation to Cooperation Framework Agreement (“CFA”). In the event we fail to meet the performance milestones under the CFA, Covestro shall draw from the letter of credit with TD. The letter of credit was secured by restricted cash of CA$ 1,000,000 under a cash use agreement which has been recorded as long-term debt in the consolidated balance sheets. We have assessed the performance milestones against ASC 606 and recognized the full contract amount as de velopment revenue in the year ended December 31, 2021. As of September 30, 2022, Covestro has issued certificates of reduction totaling EUR 325,000 and the letter of credit had an outstanding amount of $ 287,399 (EUR 275,000 ). b) During 2020, we signed a three-year supply deal with Covestro Deutschland AG, which provides early access to new photo-sensitive holographic film materials, the building block of our holographic product. We believe this agreement will not only allow early access to Covestro’s R&D library of photopolymer films but will also accelerate our product development and speed of innovation. Target markets include photonics/optical filters and holographic optical elements, diffusers, laser eye protection, optical combiners, and AR (augmented reality) applications. The agreement is valid till October 31, 2023. c) During 2018, we arranged a guarantee/standby letter of credit with RBC in favor of Satair A/S for $ 500,000 in relation to an advance payment received. In the event we fail to deliver the product as per the contract or refuse to accept the return of the product as per the buyback clause of the contract or fails to repay the advance payment in accordance with the conditions of the agreement signed with Satair on September 18, 2018, Satair shall draw from the letter of credit with RBC. Borrowings from the letter of credit with RBC are repayable on demand. The letter of credit from RBC is secured by a performance security guarantee cover issued by Export Development of Cana da. Further, this guarantee/standby letter of credit expires on October 5, 2023 . As of September 30, 2022, no amount has been drawn from the letter of credit with RBC. d) On December 8, 2016, we entered into a cooperation agreement with a large aircraft manufacturer to co-develop laser protection filters for space and aeronautical civil and military applications, metaAIR ® , and support the setup of manufacturing facilities for product certification and development. The cooperation agreement includes financial support provided to us in the form of non-recurring engineering costs of up to $ 4,000,000 to be released upon agreement of technical milestones in exchange for a royalty fee due by us on gross profit after sales and distribution costs. The total royalty fee to be paid may be adjusted based on the timing of our sales and the amount ultimately paid to us by large aircraft manufacturer to support the development. e) Certain nano-optic products are subject to a 3 % sales royalty in favour of Simon Fraser University (“SFU”) where certain elements of the nano-optic technology originated. Royalties were $ 484 during the nine months ended September 30, 2022 (2021 - $ 324 ). In 2014, our wholly owned subsidiary, Nanotech, prepaid royalties that would offset against future royalties owed as part of the transfer of the intellectual property from SFU, of which $ 196,532 remains prepaid as at September 30, 2022 (December 31, 2021 - $ 197,016 ). f) Our product revenue is associated with six patents acquired by Nanotech and are subject to royalties. We agreed to share 10 % of any revenues related to the patents received from a specific customer for a period of two years and ongoing royalties of 3 % to 6 % on other revenues derived from the patents for a period of five years . There were no royalties during the nine months ended September 30, 2022 (2021 - $ Nil ). g) As of September 30, 2022, we had ongoing commitments for maintenance contracts and asset purchases as follows: Remainder of 2022 $ 998,862 2023 218,635 2024 3,936 $ 1,221,433

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	21. Subsequent events Subsequent to September 30, 2022, 491,519 fully vested RSUs have been issued in common shares and 61,095 stock options have been exercised.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Basis of presentation	Basis of presentation — These unaudited condensed consolidated interim financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States of America (“US GAAP”). Our fiscal year-end is December 31. The condensed consolidated interim financial statements include the accounts of Meta Materials Inc. and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated on consolidation. These unaudited condensed consolidated interim financial statements do not include all of the information and notes required by US GAAP for annual financial statements. Accordingly, these unaudited condensed consolidated interim financial statements should be read in conjunction with our audited consolidated financial statements and notes for the years ended December 31, 2021, 2020 and 2019, filed with the Securities and Exchange Commission (“SEC”) on Forms 10-K and 10-K/A, respectively.
Recently adopted and issued accounting pronouncements	Recently Adopted Accounting Pronouncements: We currently have no material recently adopted accounting pronouncements. Recently Issued Accounting Pronouncements: We currently have no material recent accounting pronouncements yet to be adopted.

Acquisitions and Preferred St_2

Acquisitions and Preferred Stock Liability (Tables)	9 Months Ended
	Sep. 30, 2022
Plasma App Ltd [Member]
Business Acquisition [Line Items]
Summary of Purchase Price Consideration	The preliminary allocation of consideration paid for the PAL acquisition is summarized as follows: Amount Fair value of common stock issued (1) $ 15,290,320 Fair value of deferred consideration (2) $ 1,698,925 $ 16,989,245 Net assets of Plasma App Ltd.: Cash and cash equivalents $ 13,822 Other assets 36,103 Intangibles 6,775,728 Goodwill 10,163,592 $ 16,989,245 (1) The fair value of the common stock issued or to be issued was determined by multiplying 9,677,419 shares, calculated as per the purchase agreement, by the closing share price on April 1, 2022 of $ 1.6 . We recognized $ 9,677 in common stock and $ 15,280,645 in additional paid in capital in the interim condensed consolidated statements of changes in stockholders' equity. (2) The estimated fair value of the deferred consideration on acquisition date was determined by multiplying 1,075,268 shares, calculated as per the purchase agreement, by the closing share price on April 1, 2022 of $ 1.6 . We recognized the full amount in additional paid in capital in the interim condensed consolidated statements of changes in stockholders' equity.
Optodot Corporation [Member]
Business Acquisition [Line Items]
Summary of Purchase Price Consideration	The preliminary allocation of consideration paid for the Optodot acquisition is summarized as follows: Amount Fair value of unrestricted common stock issued or to be issued (1) $ 41,791,115 Fair value of restricted common stock issued (2) 8,342,152 Cash consideration 3,500,000 Total consideration $ 53,633,267 Net assets of Optodot: Intangibles 21,453,306 Goodwill 32,179,961 $ 53,633,267 (1) The fair value of the unrestricted common stock issued or to be issued was determined by multiplying 22,348,190 shares, calculated as per the purchase agreement, by the closing share price on June 22, 2022 of $ 1.87 . We have issued 22,305,221 shares on the closing date of June 22, 2022 and 42,969 shares are yet to be issued. As of September 30, 2022, we recognized $ 22,305 in common stock and $ 41,768,810 in additional paid in capital in the interim condensed consolidated statements of changes in stockholders' equity. (2) The fair value of the restricted common stock issued was determined by multiplying 4,461,044 shares, calculated as per the purchase agreement, by the closing share price on June 22, 2022 of $ 1.87 . The restricted common stock is subject to vesting as follows: a) Two thirds or 2,974,029 shares shall be subject to the limitations on transfer until the earlier of (A) META's achievement of at least $ 5,000,000 in revenue, from any third-party source, to the extent resulting from the sale or license of Optodot IP during the year ended June 22, 2023 and (B) June 22, 2023; b) One third or 1,487,015 shares shall be subject to the limitations on transfer until the earlier of (A) META's achievement of at least $ 10,000,000 in revenue, from any third-party source, to the extent resulting from the sale or license of Optodot IP during the year ended June 22, 2024 and (B) June 22, 2024;

Assets Held for Sale (Tables)

Assets Held for Sale (Tables)	9 Months Ended
	Sep. 30, 2022
Assets Held for Sales Disclosure [Abstract]
Schedule of Project Ownership	The Orogrande Project ownership as of September 30, 2022 is detailed as follows: Revenue Interest Working Interest University Lands - Mineral Owner 20.00 % n/a ORRI - Magdalena Royalties, LLC, an entity controlled by Gregory McCabe, Chairman 4.50 % n/a ORRI - Unrelated Party 0.50 % n/a Hudspeth Oil Corporation, a subsidiary of Meta Materials Inc. 49.88 % 66.50 % Wolfbone Investments LLC, an entity controlled by Gregory McCabe, Chairman 18.75 % 25.00 % Conversion by Note Holders in March, 2020 4.50 % 6.00 % Unrelated Party 1.88 % 2.50 % 100.00 % 100.00 %

Inventory (Tables)

Inventory (Tables)	9 Months Ended
	Sep. 30, 2022
Inventory Disclosure [Abstract]
Summary of Inventory	Inventory consists of photosensitive materials, lenses, laser protection film and finished eyewear, and is comprised of the following: As of September 30, December 31, Raw materials $ 154,267 $ 196,868 Supplies 11,584 8,886 Work in process 61,618 30,636 Finished goods 46,621 29,328 Total inventory $ 274,090 $ 265,718

Property, Plant and Equipment_2

Property, Plant and Equipment, Net (Tables)	9 Months Ended
	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Property, plant and equipment consist of the following: Useful life As of (years) September 30, December 31, Land N/A $ 434,084 $ 469,317 Building 25 5,019,494 5,509,403 Computer equipment 3 - 5 422,405 262,320 Computer software 1 304,306 277,717 Manufacturing equipment 2 - 5 22,243,051 17,762,405 Office furniture 5 - 7 577,426 525,961 Enterprise Resource Planning software 5 195,297 211,149 Leasehold Improvements 5 2,380,428 236,251 Assets under construction N/A 12,127,399 8,872,695 43,703,890 34,127,218 Accumulated depreciation and impairment ( 9,169,845 ) ( 7,109,104 ) $ 34,534,045 $ 27,018,114

Intangible Assets and Goodwill

Intangible Assets and Goodwill (Tables)	9 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangibles, Net	Intangible assets consist of the following: Useful life As of (years) September 30, December 31, Patents 5 - 10 $ 34,019,095 $ 7,839,182 Trademarks N/A 122,423 132,636 Developed technology 20 13,810,462 14,931,377 Customer contract 5 9,484,205 10,253,983 57,436,185 33,157,178 Accumulated amortization ( 6,410,757 ) ( 4,185,354 ) $ 51,025,428 $ 28,971,824
Schedule of Goodwill	Goodwill at December 31, 2021 $ 240,376,634 Business combination 10,163,592 Effect of foreign exchange on goodwill 28,512,131 Goodwill at September 30, 2022 $ 279,052,357

Long-Term Debt (Tables)

Long-Term Debt (Tables)	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Summary of Long Term Debt	As of September 30, December 31, ACOA Business Development Program (“BDP”) 2012 interest-free loan 1 with a maximum contribution of CA$ 500,000 , repayable in monthly repayments commencing October 1, 2015 of CA$ 5,952 until June 1, 2023 . Loan repayments were temporarily paused effective April 1, 2020 until January 1, 2021 as a result of the COVID-19 outbreak. As at September 30, 2022, the amount drawn down on the loan, net of repayments, is CA$ 53,571 (December 31, 2021 - CA$ 107,143 ). $ 38,058 $ 80,390 ACOA Atlantic Innovation Fund (“AIF”) 2015 interest-free loan 1,2 with a maximum contribution of CA$ 3,000,000 . Annual repayments, commencing June 1, 2021 , are calculated as a percentage of gross revenue for the preceding fiscal year, at Nil when gross revenues are less than CA$ 1,000,000 , 5 % when gross revenues are less than CA$ 10,000,000 and greater than CA$ 1,000,000 , and CA$ 500,000 plus 1 % of gross revenues when gross revenues are greater than CA$ 10,000,000 . As at September 30, 2022, the amount drawn down on the loan is CA$ 2,661,293 (December 31, 2021 - CA$ 2,924,615 ). 1,513,930 1,666,764 ACOA BDP 2018 interest-free loan 1,3 with a maximum contribution of CA$ 3,000,000 , repayable in monthly repayments commencing June 1, 2021 of CA$ 31,250 until May 1, 2029 . As at September 30, 2022, the amount drawn down on the loan, net of repayments, is CA$ 2,500,000 (December 31, 2021 - CA$ 2,781,250 ). 1,148,679 1,319,130 ACOA BDP 2019 interest-free loan 1 with a maximum contribution of CA$ 100,000 , repayable in monthly repayments commencing June 1, 2021 of CA$ 1,400 until May 1, 2027 . As at September 30, 2022, the amount drawn down on the loan, net of repayments, is CA$ 77,778 (December 31, 2021 - CA$ 90,278 ). 35,560 42,011 ACOA Regional Relief and Recovery Fund (“RRRF”) 2020 interest-free loan with a maximum contribution of CA$ 390,000 , repayable on monthly repayments commencing April 1, 2023 of CA$ 11,000 until April 1, 2026 . As at September 30, 2022, the amount drawn down on the loan is CA$ 390,000 (December 31, 2021 - CA$ 390,000 ). 144,503 120,154 2,880,730 3,228,449 Less: current portion 742,782 491,278 $ 2,137,948 $ 2,737,171 1 We were required to maintain a minimum balance of positive equity throughout the term of the loan. However, on November 14, 2019, ACOA waived this requirement for the period ending June 30, 2019 and for each period thereafter until the loan is fully repaid. 2 The carrying amount of the ACOA AIF loan is reviewed each reporting period and adjusted as required to reflect management’s best estimate of future cash flows, discounted at the original effective interest rate. 3 A portion of the ACOA BDP 2018 loan was used to finance the acquisition and construction of manufacturing equipment resulting in $ 425,872 was recorded as deferred government assistance, which is being amortized over the useful life of the associated equipment. We recorded amortization expense for the three and nine months ended September 30, 2022 of $ Nil and $ 3,047 , respectively compared to recorded amortization expense of $ 35,404 and $ 109,497 , for the three and nine months ended September 30, 2021 respectively) as government assistance in the condensed consolidated interim statements of operations and comprehensive loss. As of September 30, 2022, the portion recorded as deferred government assistance is amortized in full.

Capital Stock (Tables)

Capital Stock (Tables)	9 Months Ended
	Sep. 30, 2022
Class of Warrant or Right [Line Items]
Summary of Changes in Warrants	The following table summarizes the changes in our warrants: Nine months ended September 30, 2022 Number of warrants (#) Amount Outstanding, December 31, 2021 5,264,959 $ 6,957,974 Issued 37,337,039 18,714,297 Exercised ( 1,988,617 ) ( 251,860 ) Expired ( 692,462 ) ( 101,211 ) Outstanding, September 30, 2022 39,920,919 $ 25,319,200
Summary of Fair Value of Warrants Issued Using Block-Scholes Option Pricing Model	The fair value of warrants issued were estimated using the Black-Scholes option pricing model and have the following inputs and assumptions: Nine months ended September 30, 2022 Weighted average grant date fair value 0.53 Weighted average expected volatility 89 % Weighted average risk-free interest rate 3.18 % Weighted average expected life of the warrants 5.00

Share-Based Payments (Tables)

Share-Based Payments (Tables)	9 Months Ended
	Sep. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Summary of change in outstanding share RSUs	The following table summarizes the change in outstanding RSUs: Number of Weighted Outstanding, December 31, 2021 300,000 $ 6.43 Granted 6,676,598 3.15 Awards forfeited ( 217,445 ) 1.62 Awards vested and settled ( 224,519 ) 1.09 Outstanding, September 30, 2022 6,534,634 $ 3.31 Vested, September 30, 2022 606,919 $ 1.58
Summary of change in share outstanding options	The following table summarizes the change in our outstanding stock options: Number of Weighted Weighted Aggregate intrinsic Outstanding, December 31, 2021 21,404,641 $ 0.36 $ 7.34 $ 56,924,556 Granted 12,150,571 1.68 Forfeited ( 200,896 ) 0.74 Exercised ( 1,252,546 ) 0.27 Outstanding, September 30, 2022 32,101,770 $ 0.86 $ 9.00 $ 7,190,452 X Exercisable, September 30, 2022 22,233,380 $ 0.80 $ 8.18 $ 5,958,166
Summary of stock options outstanding	Below is a summary of the outstanding options as of September 30, 2022 and December 31, 2021: September 30, December 31, 2022 2021 Exercise price Number outstanding Number exercisable Number outstanding Number exercisable $ 0.12 518,112 518,113 518,112 518,112 0.15 369,000 369,000 369,000 369,000 0.27 17,714,087 14,471,227 19,067,529 10,893,918 0.94 957,274 45,000 — — 1.00 375,000 375,000 375,000 325,000 1.17 1,730,138 386,087 — — 1.21 1,119,120 552,752 — — 1.51 741,987 741,987 — — 1.58 5,107,941 1,305,103 — — 1.97 1,894,111 1,894,111 — — 2.00 1,075,000 1,075,000 1,075,000 1,125,000 3.47 200,000 200,000 — — 7.96 300,000 300,000 — — 32,101,770 22,233,380 21,404,641 13,231,030
Summary of fair value grant using weighted-average assumptions	The fair value of options granted was estimated at the grant date using the following weighted-average assumptions: Nine months ended September 30, Grant date fair value 0.90 Weighted average expected volatility 83 % Weighted average risk-free interest rate 2.23 % Weighted average expected life of the options 4.71 years
Restricted Stock Units (RSUs) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Summary of stock-based compensation expenses	Total stock-based compensation expense related to RSUs included in the condensed consolidated interim statements of operations was as follows: Three months ended Nine months ended September 30, September 30, 2022 2021 2022 2021 Cost of sales $ 167,779 - $ 376,250 - Selling & marketing 101,165 - 231,365 - General & administrative 519,769 - 1,036,931 - Research & development 447,707 - 1,640,939 - $ 1,236,420 - $ 3,285,485 -
Employee Stock Option Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Summary of stock-based compensation expenses	Total stock-based compensation expense related to stock options included in the condensed consolidated interim statements of operations and comprehensive loss was as follows: Three months ended Nine months ended September 30, September 30, 2022 2021 2022 2021 Selling & marketing $ 53,543 $ 5,976 $ 118,598 $ 26,935 General & administrative 506,392 93,453 4,775,793 434,135 Research & development 344,067 101,347 1,583,794 383,489 $ 904,002 $ 200,776 $ 6,478,185 $ 844,559

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended
	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Summary Of Deferred Tax Expense Benefit	Deferred tax recovery for the three and nine months ended September 30, 2022 and 2021 was as follows: Three months ended Nine months ended September 30, September 30, 2022 2021 2022 2021 Deferred tax recovery $ 37,208 $ 83,657 $ 147,193 $ 186,183

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Summary Basic and Diluted Net Loss Per Share	The following table sets forth the calculation of basic and diluted net loss per share during the periods presented: Three months ended Nine months ended September 30, September 30, 2022 2021 2022 2021 Numerator: Net loss $ ( 24,475,320 ) $ ( 11,425,248 ) $ ( 63,892,619 ) $ ( 61,467,070 ) Denominator: Weighted-average shares, basic 362,260,641 280,080,786 316,661,487 216,135,190 Weighted-average shares, diluted 362,260,641 280,080,786 316,661,487 216,135,190 Net loss per share Basic $ ( 0.07 ) $ ( 0.04 ) $ ( 0.20 ) $ ( 0.28 ) Diluted $ ( 0.07 ) $ ( 0.04 ) $ ( 0.20 ) $ ( 0.28 )
Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following potentially dilutive shares were not included in the calculation of diluted shares above as the effect would have been anti-dilutive: Three months ended Nine months ended September 30, September 30, 2022 2021 1 2022 2021 1 Options 32,101,770 24,572,014 32,101,770 24,572,014 Warrants 39,920,919 5,372,044 39,920,919 5,372,044 DSUs 3,647,026 3,455,224 3,647,026 3,455,224 RSUs 6,534,634 - 6,534,634 - 82,204,349 33,399,282 82,204,349 33,399,282 1 All references to numbers in comparative figures have been retroactively restated to reflect the number of stock of the legal parent (accounting acquiree) issuable following the reverse acquisition. The numbers of options, warrants, and DSUs issued pre-Torchlight RTO have been multiplied by 1.845 Torchlight conversion ratio.

Additional Cash Flow Informat_2

Additional Cash Flow Information (Tables)	9 Months Ended
	Sep. 30, 2022
Supplemental Cash Flow Elements [Abstract]
Summary Of Cash Flow, Operating Capital	The net changes in non-cash working capital balances related to operations consist of the following: Nine months ended September 30, 2022 2021 Grants receivable $ 145,704 $ 38,544 Inventory ( 31,543 ) 103,831 Other receivables ( 385,541 ) ( 73,436 ) Prepaid expenses ( 1,318,903 ) ( 1,342,530 ) Other current assets ( 1,961,928 ) ( 598,307 ) Trade payables ( 445,489 ) ( 258,128 ) Due from related party ( 2,105 ) ( 24,889 ) Operating lease Right-of-use Asset ( 231 ) 408,430 Operating lease liabilities ( 739,805 ) ( 18,382 ) $ ( 4,739,841 ) $ ( 1,764,867 )

Fair value measurements (Tables

Fair value measurements (Tables)	9 Months Ended
	Sep. 30, 2022
Financial Instruments Disclosure [Abstract]
Summary of Fair Value of Financial Instruments	Carrying values and fair values of financial instruments that are not carried at fair value are as follows: September 30, December 31, Financial liability Carrying value Fair value Carrying value Fair value Funding obligation $ 292,749 $ 189,020 $ 268,976 $ 170,338 Operating lease liabilities 4,042,429 5,268,962 4,370,635 6,149,369 Long-term debt 2,880,730 1,884,660 3,228,449 2,303,648

Revenue (Tables)

Revenue (Tables)	9 Months Ended
	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Summary of Revenue Disaggregated	Revenue is disaggregated as follows: Three months ended Nine months ended September 30, September 30, 2022 2021 2022 2021 Product sales $ 432,059 $ 297,431 $ 934,299 $ 321,431 Contract revenue 1 2,003,953 275,181 7,700,135 1,229,648 Other development revenue 20,000 — 120,000 242,156 Development revenue 2,023,953 275,181 7,820,135 1,471,804 $ 2,456,012 $ 572,612 $ 8,754,434 $ 1,793,235 1 A portion of contract revenue represents previously recorded deferred revenue that was recognized as revenue after satisfaction of performance obligations either through passage of time or after completion of specific performance milestones.

Deferred Revenue (Tables)

Deferred Revenue (Tables)	9 Months Ended
	Sep. 30, 2022
Deferred Revenue Disclosure [Abstract]
Summary Of Deferred Revenue	Deferred revenue consists of the following: September 30, December 31, Satair A/S-exclusive rights $ 592,626 $ 717,615 Satair A/S-advance against PO 454,075 490,929 LM Aero-MetaSOLAR commercialization — 92,698 US Deferred Revenue 75,000 75,000 Innovate UK-R&D tax credit — 18,588 Other deferred revenue 5,884 21,910 1,127,585 1,416,740 Less current portion 623,895 779,732 $ 503,690 $ 637,008

Loss on financial instruments_2

Loss on financial instruments, net (Tables)	9 Months Ended
	Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Summary of Loss on Financial Instruments, Net	Three months ended Nine months ended September 30, September 30, 2022 2021 2022 2021 Loss on unsecured convertible promissory notes – Bridge loan $ — $ — $ — $ ( 19,163,417 ) Gain on unsecured convertible promissory notes – Torchlight notes — — — ( 343,197 ) Loss on secured convertible debentures — — — ( 16,957,029 ) Loss on unsecured convertible debentures — — — ( 4,076,448 ) $ — $ - $ — $ ( 40,540,091 )

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 30, 2022
Leases [Abstract]
Summary of Operating Lease Expense	Total operating lease expense included in the condensed consolidated interim statements of operations and comprehensive loss is as follows: Three months ended Nine months ended September 30, September 30, 2022 2021 2022 2021 Operating lease expense $ 440,649 $ 87,193 $ 1,326,370 $ 187,314 Short term lease expense 199,637 86,746 358,877 140,074 Variable and other lease expense 59,678 25,244 174,021 53,128 Total $ 699,964 $ 199,183 $ 1,859,268 $ 380,516
Summary Of Future Minimum Payments Under Non-cancelable Operating Lease Obligations	Future minimum payments under non-cancelable operating lease obligations were as follows as of September 30, 2022: Remainder of 2022 $ 292,037 2023 1,166,619 2024 1,167,031 2025 1,057,062 2026 897,640 Thereafter 2,671,110 Total minimum lease payments 7,251,499 Less: interest ( 3,209,070 ) Present value of net minimum lease payments 4,042,429 Less: current portion of lease liabilities ( 864,519 ) Total long-term lease liabilities $ 3,177,910

Commitments and contingencies (

Commitments and contingencies (Tables)	9 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Summary Of Commitments For Maintenance Contracts And Asset Purchases	g) As of September 30, 2022, we had ongoing commitments for maintenance contracts and asset purchases as follows: Remainder of 2022 $ 998,862 2023 218,635 2024 3,936 $ 1,221,433

Corporate Information - Additio

Corporate Information - Additional Information (Details)	9 Months Ended
	Sep. 30, 2022
Arrangement Agreement [Member] | Torchlight [Member]
Date of acquisition agreement	Dec. 14, 2020

Acquisitions and Preferred St_3

Acquisitions and Preferred Stock Liability - Additional Information (Details)					3 Months Ended		9 Months Ended
	Jun. 22, 2022 USD ($) $ / shares shares	Apr. 01, 2022 USD ($) $ / shares shares	Oct. 05, 2021 USD ($)	Jun. 28, 2021 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($)	Oct. 05, 2021 $ / shares
Business Acquisition [Line Items]
Goodwill					$ 279,052,357		$ 279,052,357		$ 240,376,634
Revenue					2,456,012	$ 572,612	8,754,434	$ 1,793,235
Loss from operations					(22,176,598)	(11,592,892)	$ (59,227,635)	(20,921,911)
Torchlight [Member] | Meta [Member]
Business Acquisition [Line Items]
Business combination total consideration transferred value				$ 358,000,000
Goodwill				$ 213,000,000
Torchlight [Member] | Former Security Holders Of Meta [Member] | Meta [Member]
Business Acquisition [Line Items]
Percentage of voting equity interests acquired				70%
Nanotech Security Corp [Member]
Business Acquisition [Line Items]
Business acquisition effective date			Oct. 05, 2021
Percentage of voting equity interests acquired			100%
Business acquisition share price | $ / shares										$ 1.25
Business combination total consideration transferred value			$ 72,100,000
Goodwill			$ 27,100,000
Plasma App Ltd [Member]
Business Acquisition [Line Items]
Business acquisition effective date							Apr. 01, 2022
Percentage of voting equity interests acquired		100%
Business combination total consideration transferred value		$ 16,989,245
Transaction costs					400,000
Goodwill		$ 10,163,592			8,500,000		$ 8,500,000
Losses from the acquisition					(300,000)		(400,000)
Revenue					0	118,122	0	183,795
Loss from operations					0	(44,953)	(259,641)	(32,091)
Plasma App Ltd [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Business acquisition share price | $ / shares		$ 1.6
Number of shares issued as consideration for acquisition | shares		9,677,419
Value of shares issued as consideration for acquisition		$ 18,000,000
Weighted average price of stock issued pursuant to acquisitions | $ / shares		$ 1.9
Value of deferred stock to be issued pursuant to acquisitions		$ 2,000,000
Weighted Average Price of Deferred Stock to be Issued Pursuant to Acquisitions | $ / shares		$ 1.9
Number of shares to be issued as deferred consideration | shares		1,075,268
Weighted average price of stock to be issued pursuant to deferred consideration of acquisition | $ / shares		$ 1.9
Plasma App Ltd [Member] | Maximum [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Value of deferred stock to be issued pursuant to acquisitions		$ 2,000,000
Value of stock to be issued pursuant to deferred consideration of acquisition		2,000,000
Plasma App Ltd [Member] | Minimum [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Value of stock to be issued pursuant to deferred consideration of acquisition		$ 20,000
Optodot Corporation [Member]
Business Acquisition [Line Items]
Business acquisition effective date	Jun. 22, 2022
Business combination total consideration transferred value	$ 53,633,267
Cash payment	3,500,000
Transaction costs							600,000
Goodwill	$ 32,179,961
Losses from the acquisition							30,000
Revenue					0	0	41,871	121,530
Loss from operations					$ 0	$ 469,090	$ (772,395)	$ 1,393,035
Optodot Corporation [Member] | Restricted Common Stock [Member]
Business Acquisition [Line Items]
Business acquisition share price | $ / shares	$ 1.87
Number of shares issued as consideration for acquisition | shares	4,461,044
Value of shares issued as consideration for acquisition	$ 7,500,000
Optodot Corporation [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Business acquisition share price | $ / shares	$ 1.87
Number of shares issued as consideration for acquisition | shares	22,348,190
Value of shares issued as consideration for acquisition	$ 37,500,000

Acquisitions and preferred st_4

Acquisitions and preferred stock liability - Schedule of Acquisition (Details) - USD ($)	Jun. 22, 2022	Apr. 01, 2022	Sep. 30, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Goodwill			$ 279,052,357	$ 240,376,634
Plasma App Ltd [Member]
Business Acquisition [Line Items]
Fair value of common stock issued		$ 15,290,320
Fair value of deferred consideration		1,698,925
Business combination, consideration transferred		16,989,245
Cash and cash equivalents		13,822
Other assets		36,103
Intangibles		6,775,728
Goodwill		10,163,592	8,500,000
Net assets		16,989,245
Plasma App Ltd [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Fair value of common stock issued		9,677
Optodot Corporation [Member]
Business Acquisition [Line Items]
Cash consideration	$ 3,500,000
Business combination, consideration transferred	53,633,267
Intangibles	21,453,306
Goodwill	32,179,961
Net assets	53,633,267
Optodot Corporation [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Fair value of common stock issued	41,791,115		22,305
Optodot Corporation [Member] | Additional Paid-in Capital [Member]
Business Acquisition [Line Items]
Fair value of common stock issued		$ 15,280,645	$ 41,768,810
Optodot Corporation [Member] | Restricted Common Stock [Member]
Business Acquisition [Line Items]
Fair value of common stock issued	$ 8,342,152

Acquisitions and preferred st_5

Acquisitions and preferred stock liability - Schedule of Acquisition (Details) (Parenthetical) - USD ($)				9 Months Ended
		Jun. 22, 2022	Apr. 01, 2022	Sep. 30, 2022	Sep. 30, 2021
Common Stock [Member]
Business Acquisition [Line Items]
Stock issued pursuant to acquisitions	[1]			36,443,684	82,813,994
Plasma App Ltd. [Member]
Business Acquisition [Line Items]
Fair value of common stock issued			$ 15,290,320
Plasma App Ltd. [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Common stock issued or issuable			9,677,419
Share Price			$ 1.6
Fair value of common stock issued			$ 9,677
Number of shares to be issued as deferred consideration			1,075,268
Optodot Corporation [Member] | Restricted Common Stock [Member]
Business Acquisition [Line Items]
Common stock issued or issuable		4,461,044
Share Price		$ 1.87
Fair value of common stock issued		$ 8,342,152
Minimum required milestone revenue for vesting of tranche one		5,000,000
Minimum required milestone revenue for vesting of tranche two		$ 10,000,000
Optodot Corporation [Member] | Restricted Common Stock [Member] | Tranche One [Member]
Business Acquisition [Line Items]
Number of shares to be vested upon revenue mile stone achieved		2,974,029
Percentage of shares to be vested upon revenue milestone achieved		66.66%
Optodot Corporation [Member] | Restricted Common Stock [Member] | Tranche Two [Member]
Business Acquisition [Line Items]
Number of shares to be vested upon revenue mile stone achieved		1,487,015
Percentage of shares to be vested upon revenue milestone achieved		33.33%
Optodot Corporation [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Common stock issued or issuable		22,348,190
Share Price		$ 1.87
Fair value of common stock issued		$ 41,791,115		$ 22,305
Stock issued pursuant to acquisitions		22,305,221
Stock to be issued pursuant to acquisition		42,969
Optodot Corporation [Member] | Additional Paid-in Capital [Member]
Business Acquisition [Line Items]
Fair value of common stock issued			$ 15,280,645	$ 41,768,810
[1] Retroactively restated from the earliest period presented for the Torchlight RTO (“Reverse acquisition”) as described in Note 3

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Lamda Guard Technologies Ltd LGTL [Member]
Related Party Transaction [Line Items]
Due to related party, current	$ 8,552	$ 10,657

Assets Held for Sale - Addition

Assets Held for Sale - Additional Information (Details)	3 Months Ended	9 Months Ended
	Sep. 30, 2022 USD ($)	Sep. 30, 2022 USD ($)	Dec. 31, 2021 Well
Property, Plant and Equipment [Line Items]
Additional costs to ensure	$ 100,000	$ 1,600,000
Orogrande Project, West Texas [Member]
Property, Plant and Equipment [Line Items]
Drilling obligation year 2022 | Well			5
Drilling obligation year 2023 | Well			5
Fair value of property		71,700,000
Orogrande Project, West Texas [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Implied enterprise value	53,000,000	53,000,000
Orogrande Project, West Texas [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Implied enterprise value	$ 108,700,000	108,700,000
Hazel Project Property in Midland Basin [Member]
Property, Plant and Equipment [Line Items]
Fair value of property		$ 0

Assets Held for Sale - Schedule

Assets Held for Sale - Schedule of Project Ownership (Details) - Orogrande Project, West Texas [Member]	Sep. 30, 2022
Schedule of Equity Method Investments [Line Items]
Revenue Interest	100%
Working Interest	100%
University Lands - Mineral Owner [Member]
Schedule of Equity Method Investments [Line Items]
Revenue Interest	20%
ORRI - Magdalena Royalties, LLC, an Entity Controlled by Gregory McCabe, Chairman [Member]
Schedule of Equity Method Investments [Line Items]
Revenue Interest	4.50%
ORRI - Unrelated Party [Member]
Schedule of Equity Method Investments [Line Items]
Revenue Interest	0.50%
Hudspeth Oil Corporation, a subsidiary of Meta Materials Inc. [Member]
Schedule of Equity Method Investments [Line Items]
Revenue Interest	49.88%
Working Interest	66.50%
Wolfbone Investments LLC, an Entity Controlled by Gregory McCabe, Chairman [Member]
Schedule of Equity Method Investments [Line Items]
Revenue Interest	18.75%
Working Interest	25%
Conversion by Note Holders in March, 2020 [Member]
Schedule of Equity Method Investments [Line Items]
Revenue Interest	4.50%
Working Interest	6%
Unrelated Party [Member]
Schedule of Equity Method Investments [Line Items]
Revenue Interest	1.88%
Working Interest	2.50%

Inventory - Summary of Inventor

Inventory - Summary of Inventory (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Inventory Disclosure [Abstract]
Raw materials	$ 154,267	$ 196,868
Supplies	11,584	8,886
Work in process	61,618	30,636
Finished goods	46,621	29,328
Total inventory	$ 274,090	$ 265,718

Property, Plant and Equipment_3

Property, Plant and Equipment, Net - Schedule of Property and Equipment (Details) - USD ($)	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 43,703,890	$ 34,127,218
Accumulated depreciation and impairment	(9,169,845)	(7,109,104)
Property, Plant and Equipment, Net	34,534,045	27,018,114
Land [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	434,084	469,317
Building [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 5,019,494	5,509,403
Property, Plant and Equipment, Useful Life	25 years
Computer equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 422,405	262,320
Computer equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Computer equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	3 years
Computer software [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 304,306	277,717
Property, Plant and Equipment, Useful Life	1 year
Manufacturing equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 22,243,051	17,762,405
Manufacturing equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Manufacturing equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	2 years
Office furniture [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 577,426	525,961
Office furniture [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	7 years
Office furniture [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Enterprise Resource Planning software [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 195,297	211,149
Property, Plant and Equipment, Useful Life	5 years
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 2,380,428	236,251
Property, Plant and Equipment, Useful Life	5 years
Assets under construction [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 12,127,399	$ 8,872,695

Property, Plant and Equipment_4

Property, Plant and Equipment, Net - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Property, Plant and Equipment [Abstract]
Depreciation	$ 1	$ 0.4	$ 2.6	$ 1.1

Intangible Assets and Goodwil_2

Intangible Assets and Goodwill - Schedule of Intangible Assets, Net (Details) - USD ($)	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Intangibles, Gross	$ 57,436,185	$ 33,157,178
Accumulated amortization	(6,410,757)	(4,185,354)
Intangibles, Net	51,025,428	28,971,824
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Intangibles, Gross	$ 34,019,095	7,839,182
Patents [Member] | Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Intangibles, Useful Life (years)	10 years
Patents [Member] | Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Intangibles, Useful Life (years)	5 years
Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Intangibles, Gross	$ 122,423	132,636
Developed technology [Member]
Finite-Lived Intangible Assets [Line Items]
Intangibles, Gross	$ 13,810,462	14,931,377
Intangibles, Useful Life (years)	20 years
Customer contracts [Member]
Finite-Lived Intangible Assets [Line Items]
Intangibles, Gross	$ 9,484,205	$ 10,253,983
Intangibles, Useful Life (years)	5 years

Intangible Assets and Goodwil_3

Intangible Assets and Goodwill - Additional Information - (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Apr. 01, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Amortisation expense	$ 900,000	$ 200,000	$ 2,800,000	$ 700,000
Goodwill additions			10,163,592
Goodwill	279,052,357		279,052,357			$ 240,376,634
Optodot Acquisition [Member]
Finite-Lived Intangible Assets [Line Items]
Goodwill	32,200,000		32,200,000
PAL [Member]
Finite-Lived Intangible Assets [Line Items]
Goodwill	$ 8,500,000		8,500,000		$ 10,163,592
Patents [Member] | Optodot Acquisition [Member]
Finite-Lived Intangible Assets [Line Items]
Acquired intangible assets			21,500,000
Patents [Member] | PAL [Member]
Finite-Lived Intangible Assets [Line Items]
Acquired intangible assets			$ 6,800,000

Intangible Assets and Goodwil_4

Intangible Assets and Goodwill - Schedule of Goodwill (Details)	9 Months Ended
	Sep. 30, 2022 USD ($)
Goodwill [Roll Forward]
Goodwill, beginning balance	$ 240,376,634
Business combination	10,163,592
Effect of foreign exchange on goodwill	28,512,131
Goodwill, ending balance	$ 279,052,357

Long-Term Debt - Summary of Lon

Long-Term Debt - Summary of Long Term Debt (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Long-term Debt	$ 2,880,730	$ 3,228,449
Long-Term Debt, Current Maturities	742,782	491,278
Long-term Debt, Excluding Current Maturities	2,137,948	2,737,171
ACOA Business Development Program ("BDP") 2012 [Member]
Debt Instrument [Line Items]
Long-term Debt	38,058	80,390
ACOA Atlantic Innovation Fund ("AIF") 2015 [Member]
Debt Instrument [Line Items]
Long-term Debt	1,513,930	1,666,764
ACOA BDP 2018 [Member]
Debt Instrument [Line Items]
Long-term Debt	1,148,679	1,319,130
ACOA BDP 2019 [Member]
Debt Instrument [Line Items]
Long-term Debt	35,560	42,011
ACOA Regional Relief and Recovery Fund ("RRRF") 2020 [Member]
Debt Instrument [Line Items]
Long-term Debt	$ 144,503	$ 120,154

Long-Term Debt - Summary of L_2

Long-Term Debt - Summary of Long Term Debt (Parenthetical) (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2022 CAD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2022 CAD ($)	Dec. 31, 2021 CAD ($)
Debt Instrument [Line Items]
Revenues	$ 2,456,012	$ 572,612	$ 8,754,434		$ 1,793,235
ACOA Business Development Program ("BDP") 2012 [Member]
Debt Instrument [Line Items]
Long term debt maturity date	Jun. 01, 2023		Jun. 01, 2023			Jun. 01, 2023
Debt annual principal repayments commencement date			Oct. 01, 2015	Oct. 01, 2015
Maximum contribution						$ 500,000
Principal periodic payment				$ 5,952
Frequency of payment			monthly	monthly
Amount drawn down						53,571	$ 107,143
ACOA Atlantic Innovation Fund ("AIF") 2015 [Member]
Debt Instrument [Line Items]
Debt annual principal repayments commencement date			Jun. 01, 2021	Jun. 01, 2021
Maximum contribution						3,000,000
Frequency of payment			Annual	Annual
Long Term debt cumulative drawdown amount						$ 2,661,293	2,924,615
ACOA Atlantic Innovation Fund ("AIF") 2015 [Member] | Gross Revenues Are Less Than Canadian Dollar 1,000,000 [Member]
Debt Instrument [Line Items]
Percentage of annual principal repayments			0%	0%
ACOA Atlantic Innovation Fund ("AIF") 2015 [Member] | Gross Revenues Are Less Than Canadian Dollar 1,000,000 [Member] | Minimum [Member]
Debt Instrument [Line Items]
Revenues				$ 1,000,000
ACOA Atlantic Innovation Fund ("AIF") 2015 [Member] | Gross Revenues Are Less Than Canadian Dollar 10,000,000 And Greater Than Canadian Dollar 1,000,000 [Member]
Debt Instrument [Line Items]
Percentage of annual principal repayments			5%	5%
Revenues				$ 10,000,000
ACOA Atlantic Innovation Fund ("AIF") 2015 [Member] | Gross Revenues Are Less Than Canadian Dollar 10,000,000 And Greater Than Canadian Dollar 1,000,000 [Member] | Maximum [Member]
Debt Instrument [Line Items]
Revenues				10,000,000
ACOA Atlantic Innovation Fund ("AIF") 2015 [Member] | Gross Revenue Are Greater Than Canadian Dollar 10,000,000 [Member]
Debt Instrument [Line Items]
Principal periodic payment				$ 500,000
Percentage of variable annual principal repayment			1%	1%
Revenues				$ 1,000,000
ACOA BDP 2018 [Member]
Debt Instrument [Line Items]
Long term debt maturity date	May 01, 2029		May 01, 2029			May 01, 2029
Debt annual principal repayments commencement date			Jun. 01, 2021	Jun. 01, 2021
Maximum contribution						$ 3,000,000
Principal periodic payment				$ 31,250
Frequency of payment			monthly	monthly
Deferred government assistance	$ 425,872		$ 425,872
Amortization of deferred government assistance	$ 0	$ 35,404	$ 3,047		$ 109,497
Long Term debt cumulative drawdown amount						$ 2,500,000	2,781,250
ACOA BDP 2019 [Member]
Debt Instrument [Line Items]
Long term debt maturity date	May 01, 2027		May 01, 2027			May 01, 2027
Debt annual principal repayments commencement date			Jun. 01, 2021	Jun. 01, 2021
Maximum contribution						$ 100,000
Principal periodic payment				$ 1,400
Frequency of payment			monthly	monthly
Long Term debt cumulative drawdown amount						$ 77,778	90,278
ACOA Regional Relief and Recovery Fund ("RRRF") 2020 [Member]
Debt Instrument [Line Items]
Long term debt maturity date	Apr. 01, 2026		Apr. 01, 2026			Apr. 01, 2026
Debt annual principal repayments commencement date			Apr. 01, 2023	Apr. 01, 2023
Maximum contribution						$ 390,000
Principal periodic payment				$ 11,000
Frequency of payment			monthly	monthly
Long Term debt cumulative drawdown amount						$ 390,000	$ 390,000

Capital Stock - Additional Info

Capital Stock - Additional Information (Details)				3 Months Ended		9 Months Ended
		Jun. 27, 2022 USD ($) $ / shares shares	May 10, 2022 $ / shares shares	Sep. 30, 2022 USD ($) $ / shares shares	Sep. 30, 2021 USD ($) shares	Sep. 30, 2022 USD ($) $ / shares shares	Sep. 30, 2021 USD ($) shares	Dec. 31, 2021 $ / shares
Class of Stock [Line Items]
Common stock, shares authorized				1,000,000,000		1,000,000,000
Common stock, shares par value | $ / shares				$ 0.001		$ 0.001		$ 0.001
Options exercised to purchase equal number of common shares						1,252,546
Warrant expiration term		5 years 6 months
Common stock consideration | $	[1]			$ 2,557,530	$ 3,833,485	$ 10,626,399	$ 5,269,407
Non-Employee [Member]
Class of Stock [Line Items]
Number of securities called by warrant			300,000
Warrants exercise price | $ / shares			$ 1.18
Warrant expiration term			5 years
Securities Purchase Agreement [Member]
Class of Stock [Line Items]
Number of securities called by warrant		37,037,039
Warrants exercise price | $ / shares		$ 1.75
Gross proceeds from issuance of common stock | $		$ 50,000,000
Proceeds from Issuance of Common Stock | $		$ 46,300,000
Share price | $ / shares		$ 1.15
Warrants fair value | $		$ 18,500,000
Warrant expiration term						5 years 6 months
Prior to Completion of the CPM RTO [Member] | Torch Light Conversion Ratio [Member]
Class of Stock [Line Items]
Common stock, coversion ratio						1.845
Prior to Completion of the CPM RTO [Member] | Common Stock Shares Issued pre-Torchlight RTO [Member]
Class of Stock [Line Items]
Common stock, coversion ratio						1.845
Factor considered for common stock issuance						0.001
Common Stock [Member]
Class of Stock [Line Items]
Options exercised to purchase equal number of common shares	[1]			120,269	1,226,375	1,252,546	1,640,294
Common stock consideration | $	[1]			$ 223	$ 149	$ 223	$ 479
Common Stock [Member] | Securities Purchase Agreement [Member]
Class of Stock [Line Items]
Number of shares issued		37,037,039
Purchase price of per share | $ / shares		$ 1.35
Warrants exercise price | $ / shares		$ 1.75
Common stock fair value | $		$ 27,900,000
Common Stock [Member] | Plasma Acquisition [Member]
Class of Stock [Line Items]
Number of shares issued as consideration for acquisition						9,677,419
Common Stock [Member] | Optodot Acquisition [Member]
Class of Stock [Line Items]
Number of shares issued as consideration for acquisition						26,766,265
Common Stock [Member] | Optodot Acquisition [Member] | Service Provider [Member]
Class of Stock [Line Items]
Share price | $ / shares				$ 1.87		$ 1.87
Common stock issued as stock-based compensation to service provider						223,052
Common Stock [Member] | Restricted Stock Units (RSUs) [Member]
Class of Stock [Line Items]
Stock units vested and settled equal number of common shares						224,519
Warrant [Member]
Class of Stock [Line Items]
Warrants exercised to purchase common shares						1,988,617
Difference shares withheld to cover exercise cost						364,929
Number of securities called by warrant		37,037,039		1,623,700		1,623,700
[1] Retroactively restated from the earliest period presented for the Torchlight RTO (“Reverse acquisition”) as described in Note 3

Capital Stock - Summary of Chan

Capital Stock - Summary of Changes in Warrants (Details) - Warrant [Member]	9 Months Ended
	Sep. 30, 2022 USD ($) shares
Class of Warrant or Right [Line Items]
Balance, beginning of period, shares | shares	5,264,959
Balance, beginning of period | $	$ 6,957,974
Issued, shares | shares	37,337,039
Issued | $	$ 18,714,297
Exercised, shares | shares	(1,988,617)
Exercised | $	$ (251,860)
Expired, Shares | shares	(692,462)
Expired | $	$ (101,211)
Balance, end of period, shares | shares	39,920,919
Balance, end of period | $	$ 25,319,200

Capital Stock - Summary of Fair

Capital Stock - Summary of Fair Value of Warrants Issued Using Block-Scholes Option Pricing Model (Details) - Black-Scholes Option Pricing Model [Member] - Weighted Average [Member]	Sep. 30, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.53
Warrants and Rights Outstanding, Term	5 years
Risk free interest rate [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants and Rights Outstanding, Measurement Input	3.18
Expected volatility [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants and Rights Outstanding, Measurement Input	89

Share-Based Payments - Addition

Share-Based Payments - Additional Information (Details) - shares	9 Months Ended
	Sep. 30, 2022	Dec. 03, 2021
2015 Stock Option and Grant Plan [Member]
Shares reserved for future issuance		3,500,000
2018 Stock Option and Grant Plan [Member]
Shares reserved for future issuance		6,445,745
2021 Equity Incentive Plan [Member]
Shares reserved for future issuance		34,945,745
DSU Plan [Member]
Number of shares outstanding	3,647,026
Number of shares issued	0
Number of shares exercised	0
Number of shares expired	0

Share-Based Payments - Summary

Share-Based Payments - Summary of Stock-Based Compensation Expenses (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Restricted Stock Units (RSUs) [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 1,236,420		$ 3,285,485
Restricted Stock Units (RSUs) [Member] | Cost of Sales [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	167,779		376,250
Restricted Stock Units (RSUs) [Member] | Selling & Marketing
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	101,165		231,365
Restricted Stock Units (RSUs) [Member] | General & Administrative
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	519,769		1,036,931
Restricted Stock Units (RSUs) [Member] | Research & Development
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	447,707		1,640,939
Employee Stock Option Plan [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	904,002	$ 200,776	6,478,185	$ 844,559
Employee Stock Option Plan [Member] | Selling & Marketing
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	53,543	5,976	118,598	26,935
Employee Stock Option Plan [Member] | General & Administrative
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	506,392	93,453	4,775,793	434,135
Employee Stock Option Plan [Member] | Research & Development
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 344,067	$ 101,347	$ 1,583,794	$ 383,489

Share-Based Payments - Summar_2

Share-Based Payments - Summary of change in outstanding share RSUs (Details) - Restricted Stock Units (RSUs) [Member]	9 Months Ended
	Sep. 30, 2022 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Outstanding, beginning of period, Number of RSUs | shares	300,000
Granted, Number of RSUs | shares	6,676,598
Awards forfeited | shares	(217,445)
Awards vested and settled | shares	(224,519)
Outstanding, end of period, Number of RSUs | shares	6,534,634
Vested, end of period, Number of RSUs | shares	606,919
Outstanding, beginning of period, Weighted Average grant date fair value | $ / shares	$ 6.43
Granted, Weighted Average grant date fair value | $ / shares	3.15
Awards forfeited, Weighted Average grant date fair value | $ / shares	1.62
Awards Vested and settled, Weighted Average grant date fair value | $ / shares	1.09
Outstanding, end of period, Weighted Average grant date fair value | $ / shares	3.31
Vested, end of period, Weighted Average grant date fair value | $ / shares	$ 1.58

Share-Based Payments - Summar_3

Share-Based Payments - Summary of Change in Share Outstanding Options (Details)	9 Months Ended	12 Months Ended
	Sep. 30, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Outstanding, beginning of period, Number of Options | shares	21,404,641
Granted, Number of Options | shares	12,150,571
Forfeited, Number of Options | shares	(200,896)
Exercised, Number of Options | shares	(1,252,546)
Outstanding, end of period, Number of Options | shares	32,101,770	21,404,641
Exercisable, end of period | shares	22,233,380	13,231,030
Outstanding, beginning of period, Weighted Average exercise price per stock option | $ / shares	$ 0.36
Granted, Weighted Average exercise price per stock option | $ / shares	1.68
Forfeited, Weighted Average exercise price per stock option | $ / shares	0.74
Exercised, Weighted Average exercise price per stock option | $ / shares	0.27
Outstanding, end of period, Weighted Average exercise price per stock option | $ / shares	0.86	$ 0.36
Exercisable, end of period | $ / shares	$ 0.80
Outstanding, Weighted Average exercise remaining contractual term (years)	9 years	7 years 4 months 2 days
Exercisable, Weighted Average exercise remaining contractual term (years)	8 years 2 months 4 days
Outstanding, Aggregate intrinsic value | $	$ 7,190,452	$ 56,924,556
Exercisable, Aggregate intrinsic value | $	$ 5,958,166

Share-Based Payments - Summar_4

Share-Based Payments - Summary of Stock Options Outstanding (Details) - shares	Sep. 30, 2022	Dec. 31, 2021
Schedule of Stock Options Outstanding [Line Items]
Number outstanding	32,101,770	21,404,641
Number exercisable	22,233,380	13,231,030
$0.12 [Member]
Schedule of Stock Options Outstanding [Line Items]
Number outstanding	518,112	518,112
Number exercisable	518,113	518,112
$0.15 [Member]
Schedule of Stock Options Outstanding [Line Items]
Number outstanding	369,000	369,000
Number exercisable	369,000	369,000
$0.27 [Member]
Schedule of Stock Options Outstanding [Line Items]
Number outstanding	17,714,087	19,067,529
Number exercisable	14,471,227	10,893,918
0.94 [Member]
Schedule of Stock Options Outstanding [Line Items]
Number outstanding	957,274
Number exercisable	45,000
$1.00 [Member]
Schedule of Stock Options Outstanding [Line Items]
Number outstanding	375,000	375,000
Number exercisable	375,000	325,000
$1.17 [Member]
Schedule of Stock Options Outstanding [Line Items]
Number outstanding	1,730,138
Number exercisable	386,087
$1.21 [Member]
Schedule of Stock Options Outstanding [Line Items]
Number outstanding	1,119,120
Number exercisable	552,752
$1.51 [Member]
Schedule of Stock Options Outstanding [Line Items]
Number outstanding	741,987
Number exercisable	741,987
$1.58 [Member]
Schedule of Stock Options Outstanding [Line Items]
Number outstanding	5,107,941
Number exercisable	1,305,103
$1.97 [Member]
Schedule of Stock Options Outstanding [Line Items]
Number outstanding	1,894,111
Number exercisable	1,894,111
$2.00 [Member]
Schedule of Stock Options Outstanding [Line Items]
Number outstanding	1,075,000	1,075,000
Number exercisable	1,075,000	1,125,000
$3.47 [Member]
Schedule of Stock Options Outstanding [Line Items]
Number outstanding	200,000
Number exercisable	200,000
$7.96 [Member]
Schedule of Stock Options Outstanding [Line Items]
Number outstanding	300,000
Number exercisable	300,000

Share-Based Payments - Summar_5

Share-Based Payments - Summary of Stock Options Outstanding (Parenthetical) (Details) - $ / shares	Sep. 30, 2022	Dec. 31, 2021
Schedule Of Stock Options Outstanding [Line Items]
Exercise price	$ 0.86	$ 0.36
$0.27 [Member]
Schedule Of Stock Options Outstanding [Line Items]
Exercise price	0.27	0.27
$0.12 [Member]
Schedule Of Stock Options Outstanding [Line Items]
Exercise price	0.12	0.12
$0.15 [Member]
Schedule Of Stock Options Outstanding [Line Items]
Exercise price	0.15	0.15
0.94 [Member]
Schedule Of Stock Options Outstanding [Line Items]
Exercise price	0.94	0.94
$2.00 [Member]
Schedule Of Stock Options Outstanding [Line Items]
Exercise price	2	2
$1.00 [Member]
Schedule Of Stock Options Outstanding [Line Items]
Exercise price	1	1
$3.47 [Member]
Schedule Of Stock Options Outstanding [Line Items]
Exercise price	3.47	3.47
$7.96 [Member]
Schedule Of Stock Options Outstanding [Line Items]
Exercise price	7.96	7.96
$1.97 [Member]
Schedule Of Stock Options Outstanding [Line Items]
Exercise price	1.97	1.97
$1.58 [Member]
Schedule Of Stock Options Outstanding [Line Items]
Exercise price	1.58	1.58
$1.51 [Member]
Schedule Of Stock Options Outstanding [Line Items]
Exercise price	1.51	1.51
$1.21 [Member]
Schedule Of Stock Options Outstanding [Line Items]
Exercise price	1.21	1.21
$1.17 [Member]
Schedule Of Stock Options Outstanding [Line Items]
Exercise price	$ 1.17	$ 1.17

Share-Based Payments - Summar_6

Share-Based Payments - Summary of Fair Value Grant Using Weighted-Average Assumptions (Details)	9 Months Ended
	Sep. 30, 2022 $ / shares
Schedule Of Share Based Payment Award Stock Options Valuation Assumptions [Line Items]
Grant date fair value	$ 0.90
Weighted average expected volatility	83%
Weighted average risk-free interest rate	2.23%
Weighted average expected life of the options	4 years 8 months 15 days

Income Taxes - Summary Of Defer

Income Taxes - Summary Of Deferred Tax Expense Benefit (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Deferred tax recovery	$ 37,208	$ 83,657	$ 147,193	$ 186,183

Net Loss Per Share - Summary Ba

Net Loss Per Share - Summary Basic and Diluted Net Loss Per Share (Details) - USD ($)		3 Months Ended		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Numerator:
Net loss		$ (24,475,320)	$ (11,425,248)	$ (63,892,619)	$ (61,467,070)
Denominator:
Weighted-average shares, basic	[1]	362,260,641	280,080,786	316,661,487	216,135,190
Weighted-average shares, diluted	[1]	362,260,641	280,080,786	316,661,487	216,135,190
Net loss per share
Basic	[1]	$ (0.07)	$ (0.04)	$ (0.20)	$ (0.28)
Diluted	[1]	$ (0.07)	$ (0.04)	$ (0.20)	$ (0.28)
[1] Retroactively restated for the nine months ended September 30, 2021 for the Torchlight RTO (“Reverse Acquisition”) as described in Note 3

Net Loss Per Share - Summary of

Net Loss Per Share - Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	82,204,349	33,399,282	82,204,349	33,399,282
Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	32,101,770	24,572,014	32,101,770	24,572,014
Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	39,920,919	5,372,044	39,920,919	5,372,044
DSUs [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	3,647,026	3,455,224	3,647,026	3,455,224
RSUs [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	6,534,634		6,534,634

Net Loss Per Share - Summary _2

Net Loss Per Share - Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share (Parenthetical) (Details)	9 Months Ended
	Sep. 30, 2022
Torch Light Conversion Ratio [Member] | Prior to Completion of Torchlight RTO [Member]
Class of Stock [Line Items]
Common stock, coversion ratio	1.845

Additional Cash Flow Informat_3

Additional Cash Flow Information - Summary of Cash Flow, Operating Capital (Details) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Increase (Decrease) in Operating Capital [Abstract]
Grants receivable	$ 145,704	$ 38,544
Inventory	(31,543)	103,831
Other receivables	(385,541)	(73,436)
Prepaid expenses	(1,318,903)	(1,342,530)
Other current assets	(1,961,928)	(598,307)
Trade payables	(445,489)	(258,128)
Due from related party	(2,105)	(24,889)
Operating lease Right-of-use Asset	(231)	408,430
Operating lease liabilities	(739,805)	(18,382)
Total	$ (4,739,841)	$ (1,764,867)

Fair value measurements - Summa

Fair value measurements - Summary of Fair Value of Financial Instruments (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Funding obligation	$ 292,749	$ 268,976
Operating lease liabilities	4,042,429	4,370,635
Long-term debt	2,880,730	3,228,449
Fair Value [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Funding obligation	189,020	170,338
Operating lease liabilities	5,268,962	6,149,369
Long-term debt	$ 1,884,660	$ 2,303,648

Revenue - Additional Informatio

Revenue - Additional Information (Details)		3 Months Ended		9 Months Ended		12 Months Ended
		Sep. 30, 2022 USD ($) Customer	Sep. 30, 2021 USD ($) Customer	Sep. 30, 2022 USD ($) Customer Segment	Sep. 30, 2021 USD ($) Customer	Dec. 31, 2021 USD ($)
Disaggregation of Revenue [Line Items]
Number of operating segment | Segment				1
Total revenue		$ 2,456,012	$ 572,612	$ 8,754,434	$ 1,793,235
Development contract value						$ 41,500,000
Development contract period maximum						5 years
Contract revenue [Member]
Disaggregation of Revenue [Line Items]
Number of major customers | Customer		1	1	1	1
Total revenue	[1]	$ 2,003,953	$ 275,181	$ 7,700,135	$ 1,229,648
Contract revenue [Member] | One Customer [Member]
Disaggregation of Revenue [Line Items]
Total revenue		$ 2,000,000	$ 300,000	$ 7,500,000	$ 700,000
Contract revenue [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | One Customer [Member]
Disaggregation of Revenue [Line Items]
Concentration risk, percentage		82%	51%	86%	40%
[1] A portion of contract revenue represents previously recorded deferred revenue that was recognized as revenue after satisfaction of performance obligations either through passage of time or after completion of specific performance milestones.

Revenue - Summary of Revenue Di

Revenue - Summary of Revenue Disaggregated (Details) - USD ($)		3 Months Ended		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax		$ 2,456,012	$ 572,612	$ 8,754,434	$ 1,793,235
Product sales [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax		432,059	297,431	934,299	321,431
Contract revenue [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	[1]	2,003,953	275,181	7,700,135	1,229,648
Other development revenue [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax		20,000		120,000	242,156
Development revenue [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax		$ 2,023,953	$ 275,181	$ 7,820,135	$ 1,471,804
[1] A portion of contract revenue represents previously recorded deferred revenue that was recognized as revenue after satisfaction of performance obligations either through passage of time or after completion of specific performance milestones.

Deferred Revenue - Summary of D

Deferred Revenue - Summary of Deferred Revenue (Detail) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Deferred Revenue Arrangement [Line Items]
Deferred Revenue	$ 1,127,585	$ 1,416,740
Less current portion	623,895	779,732
Satair A/S-Exclusive Rights [Member]
Deferred Revenue Arrangement [Line Items]
Deferred Revenue	592,626	717,615
Satair A/S-Advance Against PO [Member]
Deferred Revenue Arrangement [Line Items]
Deferred Revenue	454,075	490,929
LM Aero-MetaSOLAR Commercialization [Member]
Deferred Revenue Arrangement [Line Items]
Deferred Revenue		92,698
US Deferred Revenue [Member]
Deferred Revenue Arrangement [Line Items]
Deferred Revenue	75,000	75,000
Innovate UK-R&D Tax Credit [Member]
Deferred Revenue Arrangement [Line Items]
Deferred Revenue		18,588
Other Deferred Revenue [Member]
Deferred Revenue Arrangement [Line Items]
Deferred Revenue	$ 5,884	$ 21,910

Loss on financial instruments_3

Loss on financial instruments, net - Summary of Loss on Financial Instruments, Net (Details)	9 Months Ended
	Sep. 30, 2021 USD ($)
Derivative Instruments, Gain (Loss) [Line Items]
Loss on secured convertible debentures	$ (16,957,029)
Loss on unsecured convertible debentures	(4,076,448)
Gain (Loss) on derivative instruments, net	(40,540,091)
Bridge Loan [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) on unsecured convertible promissory notes	(19,163,417)
Torchlight Notes [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) on unsecured convertible promissory notes	$ (343,197)

Leases - Additional Information

Leases - Additional Information (Details)	Feb. 25, 2022 ft²	Sep. 30, 2022 USD ($)	Jun. 30, 2022 USD ($)	Dec. 31, 2021 USD ($)
Operating lease right-of-use assets		$ 5,366,070		$ 6,278,547
Operating lease liability		$ 4,042,429
Burnaby [Member]
Lease, term of contract	2 years 11 months
Land under lease | ft²	1,994
Operating lease right-of-use assets			$ 146,822
Operating lease liability			$ 146,822
Lease commencement date	Jun. 01, 2022

Leases - Summary of Operating L

Leases - Summary of Operating Lease Expense (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Lease, Cost [Abstract]
Operating lease expense	$ 440,649	$ 87,193	$ 1,326,370	$ 187,314
Short term lease expense	199,637	86,746	358,877	140,074
Variable and other lease expense	59,678	25,244	174,021	53,128
Total	$ 699,964	$ 199,183	$ 1,859,268	$ 380,516

Leases - Summary of Future Mini

Leases - Summary of Future Minimum Payments Under Non-cancelable Operating Lease Obligations (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]
Remainder of 2022	$ 292,037
2023	1,166,619
2024	1,167,031
2025	1,057,062
2026	897,640
Thereafter	2,671,110
Total minimum lease payments	7,251,499
Less: interest	(3,209,070)
Present value of net minimum lease payments	4,042,429
Less: current portion of lease liabilities	(864,519)	$ (663,861)
Total long-term lease liabilities	$ 3,177,910	$ 3,706,774

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details)				9 Months Ended
	Jul. 25, 2022 USD ($)	Mar. 18, 2021 USD ($)	Apr. 30, 2020 USD ($)	Sep. 30, 2022 USD ($) Patent	Sep. 30, 2021 USD ($)	Sep. 30, 2022 EUR (€)	Dec. 31, 2021 USD ($)	Jan. 29, 2021 EUR (€)	Jan. 29, 2021 CAD ($)	Dec. 31, 2018 USD ($)
Contractual obligation				$ 292,749			$ 268,976
Royalties				$ 0	$ 0
Number of patents | Patent				6
Cooperation Framework Agreement CFA [Member] | Letter of Credit [Member]
Line of credit facility				$ 287,399		€ 275,000
Cooperation Framework Agreement CFA [Member] | Letter of Credit [Member] | Restricted Cash [Member]
Debt instrument, collateral amount									$ 1,000,000
Co Operation Agreement [Member]
Contractual obligation				$ 4,000,000
Covestro Deutschland AG Covestro [Member] | Cooperation Framework Agreement CFA [Member] | Letter of Credit [Member]
Cash transferred from restricted cash to cash and cash equivalents | €						€ 325,000
Datalog LWT, Inc. d/b/a Cordax Evaluation Technologies [Member]
Monetary relief, sought value		$ 104,500.01
Loss contingency, trial				The parties are now engaged in discovery and plan to take depositions of fact and expert witnesses. We are currently identifying and vetting potential expert witnesses. Management is open to an agreed resolution if such an agreement can be reached but is prepared to proceed to trial on the claims, which is currently set for April 17, 2023.
Simon Fraser University [Member]
Sales royalty				3%
Royalties				$ 484	$ 324
Prepaid royalties				196,532			$ 197,016
Toronto Dominion Bank TD [Member] | Covestro Deutschland AG Covestro [Member] | Cooperation Framework Agreement CFA [Member] | Letter of Credit [Member]
Line of credit facility, maximum borrowing capacity | €								€ 600,000
RBC [Member] | Satair [Member] | Letter of Credit [Member]
Line of credit facility, maximum borrowing capacity										$ 500,000
Line of credit facility				$ 0
Debt instrument expiry date				Oct. 05, 2023
Tool Failure during Drilling Activities [Member] | Datalog LWT, Inc. d/b/a Cordax Evaluation Technologies [Member]
Estimated recovery amount on the costs incurred of tool failure			$ 1,400,000
Breach of Contract [Member] | WestPark Capital Group, LLC [Member]
Monetary relief, sought value	$ 450,000
Breach of Contract [Member] | Cordax Evaluation Technologies [Member]
Monetary relief, sought value			$ 104,500
Securities Class Action [Member]
Loss contingency, trial				Lead plaintiffs filed a consolidated complaint on August 29, 2022. We moved to dismiss that complaint on October 13, 2022.
Nanotech Security Corp [Member]
Contractual obligation				$ 1,221,433
Remainder of 2022				998,862
2023				218,635
2024				$ 3,936
Revenue from Specific Customer [Member]
Percentage share of revenue related to patents				10%
Number of years revenue shared				2 years
Other Revenue [Member]
Number of years revenue shared				5 years
Other Revenue [Member] | Maximum [Member]
Percentage share of revenue related to patents				6%
Other Revenue [Member] | Minimum [Member]
Percentage share of revenue related to patents				3%

Subsequent Events - Additional

Subsequent Events - Additional Information (Details) - shares		9 Months Ended
	Oct. 01, 2022	Sep. 30, 2022
Subsequent Event [Line Items]
Exercise of stock options, Shares		1,252,546
Subsequent Event [Member]
Subsequent Event [Line Items]
Exercise of stock options, Shares	61,095
Subsequent Event [Member] | RSUs [Member]
Subsequent Event [Line Items]
Vested shares	491,519